Id,Country,City,Latitude,Longitude,NCTNumber,Disease,Condition,Intervention,Phases,Enrollment,PrincipalInvestigationLocation
1,united states of america,new york,40.7141667,-74.0063889,NCT02369926,Multiple Sclerosis,RRMS,Other,Phase 2,20,Icahn School of Medicine at Mount Sinai
2,italy,sassari,40.727222,8.560278,NCT02010398,Multiple Sclerosis,All,Other,Phase 1-Phase 2,45,Department of Biomedical Sciences- University of Sassari
3,italy,sassari,40.727222,8.560278,NCT02010398,Multiple Sclerosis,All,Other,Phase 1-Phase 2,45,Department of Clinical and Experimental Medicine - University of Sassari
4,italy,sassari,40.727222,8.560278,NCT02010398,Multiple Sclerosis,All,Other,Phase 1-Phase 2,45,Department of Surgery - Microsurgery and Medical-Surgical Specialties
5,united states of america,baltimore,39.2902778,-76.6125,NCT02346734,Multiple Sclerosis,All,Device,N/A,170,University of Maryland
6,brazil,sao paulo,-23.473293,-46.665803,NCT02489877,Multiple Sclerosis,All,Other,N/A,84,Faculdade de Ciências Médicas da Santa Casa de São Paulo
7,italy,milan,45.466667,9.2,NCT02364505,Multiple Sclerosis,All,Behavioral,N/A,120,Fondazione Don Carlo Gnocchi Onlus
8,united states of america,salt lake city,40.7608333,-111.8902778,NCT01737372,Multiple Sclerosis,All,Other,Phase 1,45,Rocky Mountain MS Clinic
9,finland,turku,60.45,22.283333,NCT02403570,Multiple Sclerosis,RRMS,Other,N/A,80,Division of Clinical Neurosciences - Turku University Hospital
10,united states of america,kenmore,47.7575,-122.2427778,NCT01711255,Multiple Sclerosis,All,Other,N/A,100,Bastyr University Clinical Research Center
11,germany,rostock,54.083333,12.133333,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,University of Rostock - Albrecht-Kossel-Institute for Neuroregeneration
12,germany,aachen,50.770833,6.105278,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universitätsklinikum Aachen - Klink für Neurologie
13,germany,asbach,49.816667,7.283333,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Kamillusklinik - Abtl. Neurologie
14,germany,berlin,52.516667,13.4,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Berlin Charite - Klinisches und experimentelles Forschungszentrum für Multiple Sklerose
15,germany,berlin,52.516667,13.4,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Jüdisches Krankenhaus Berlin - Abt. Neurologie
16,germany,dusseldorf,51.216667,6.766667,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,HHU Düsseldorf - Klinik und Poliklinik für Neurologie
17,germany,essen,51.45,7.016667,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Alfried Krupp Krankenhaus Rüttenscheid - Abt. Neurologie
18,germany,giessen,50.583333,8.65,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universitätsklinikum Gießen und Marburg - Neurovaskuläre AG
19,germany,isselburg,51.833333,6.466667,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Augustahospital AnholT GmbH - Abt. Neurologie
20,germany,munster,51.966667,7.633333,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universität Münster - Klinik & Poliklinik für Neurologie
21,germany,trier,49.75,6.633333,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Krankenhaus der Bamherzigen Brüder Trier - Neurologische Klinik
22,germany,ulm,48.4,10,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universitätsklinikum Ulm - Klinik für Neurologie
23,germany,wurzburg,49.787778,9.936111,NCT01271699,Multiple Sclerosis,All,Other,N/A,250,Universitätsklinik Würzburg - Neurologische Klinik
24,france,montpellier,43.61092,3.87723,NCT02580669,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,66,Hopital Gui de Chauliac -Service de Neurologie
25,united kingdom,bristol,51.45,-2.583333,NCT01815632,Multiple Sclerosis,Progressive Multiple Sclerosis,Stem Cells,Phase 2,80,University of Bristol & North Bristol NHS Trust
26,united states of america,los angeles,34.0522222,-118.2427778,NCT01466114,Multiple Sclerosis,RRMS,Drug,Phase 2,64,University of California - Los Angeles
27,united states of america,aurora,39.7294444,-104.8313889,NCT01466114,Multiple Sclerosis,RRMS,Drug,Phase 2,64,The University of Colorado Denver
28,united states of america,albuquerque,35.0844444,-106.6505556,NCT01466114,Multiple Sclerosis,RRMS,Drug,Phase 2,64,The University of New Mexico
29,united states of america,philadelphia,39.9522222,-75.1641667,NCT01466114,Multiple Sclerosis,RRMS,Drug,Phase 2,64,The University of Pennsylvania
30,spain,barcelona,41.398371,2.1741,NCT02495766,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,8,Hospital Vall Hebron
31,germany,muenster,51.966667,7.633333,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,University Hospital Muenster
32,germany,bonn,50.733333,7.1,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,Neurologisches Studienzentrum Dr. Schmidt/Dr. Neudecker/ Dr. Viehbahn/Dr. Kronenberger
33,germany,frankfurt,50.116667,8.683333,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,Neurologische Gemeinschaftspraxis im Bienenkorbhaus
34,germany,heidelberg,49.416667,8.7,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,Neurologische Univ.-Klinik
35,germany,mainz,50,8.271111,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,Klinik und Poliklinik für Neurologie - Universitätsklinikum Mainz
36,germany,osnabruck,52.266667,8.05,NCT02461069,Multiple Sclerosis,RRMS,Drug,Phase 4,75,MVZ-Neurologie Klinikum Osnabrück GmbH
37,denmark,copenhagen,55.666667,12.583333,NCT02760082,Multiple Sclerosis,All,Other,N/A,500,University of Copenhagen
38,united states of america,waltham,42.3763889,-71.2361111,NCT02486562,Multiple Sclerosis,All,Behavioral,N/A,20000,Accelerated Cure Project
39,united states of america,san francisco,37.775,-122.4183333,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,UCSF Pediatric MS Center
40,united states of america,birmingham,33.5205556,-86.8025,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Center for pediatric-onset demyelinating diseases at the Children's Hospital of Alabama - Birmingham
41,united states of america,san bernardino,34.1083333,-117.2888889,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Children's Hospital - Loma Linda University
42,united states of america,aurora,39.7294444,-104.8313889,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Children's Hospital Colorado - University of Colorado School of Medicine
43,united states of america,washington,38.895,-77.0366667,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Children's National Medical Center
44,united states of america,chicago,41.85,-87.65,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Ann & Robert H. Lurie Children's Hospital of Chicago
45,united states of america,boston,42.3583333,-71.0602778,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Partners Pediatric MS Center at the Massachusetts General Hospital for Children
46,united states of america,boston,42.3583333,-71.0602778,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Children's Hospital Boston
47,united states of america,rochester,44.0216667,-92.4697222,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Regional Pediatric MS Center at Mayo Clinic
48,united states of america,saint louis,38.6272222,-90.1977778,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Washington University School of Medicine
49,united states of america,buffalo,42.8863889,-78.8786111,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Center of the Jacobs Neurological Institute - University of Buffalo
50,united states of america,stony brook,40.9255556,-73.1413889,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Stony Brook National Pediatric MS Center
51,united states of america,cleveland,41.4994444,-81.6955556,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,The Cleveland Clinic
52,united states of america,philadelphia,39.9522222,-75.1641667,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Clinic - Children's Hospital of Philadelphia
53,united states of america,dallas,32.7833333,-96.8,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric MS Center - University of Texas - Southwestern Medical Center
54,united states of america,houston,29.7630556,-95.3630556,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,The Blue Bird Circle Clinic for MS at Texas Children's Hospital
55,united states of america,salt lake city,40.7608333,-111.8902778,NCT01396343,Multiple Sclerosis,CIS,Other,Phase 1,1920,Pediatric Neurology Clinic - Primary Children's Hospital
56,italy,ferrara,44.833333,11.583333,NCT02421744,Multiple Sclerosis,All,Behavioral,Phase 3,60,Ferrara University Hospital
57,italy,pisa,43.716667,10.383333,NCT02421744,Multiple Sclerosis,All,Behavioral,Phase 3,60,Azienda Ospedaliera Universitaria Pisana
58,united states of america,baltimore,39.2902778,-76.6125,NCT02538094,Multiple Sclerosis,Progressive Multiple Sclerosis,Device,N/A,50,Johns Hopkins University
59,switzerland,valens,46.966581,9.477047,NCT02408367,Multiple Sclerosis,All,Behavioral,Phase 1,20,Kliniken-Valens
60,ireland,merrion,53.295,-6.2372222,NCT02208050,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 4,80,St Vincent's University Hospital
61,ireland,dublin,53.3330556,-6.2488889,NCT02208050,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 4,80,St. Vincents University Hospital
62,united kingdom,london,51.514125,-0.093689,NCT02490046,Multiple Sclerosis,All,Other,Phase 1,20,The National Hospital for Neurology and Neurosurgery
63,united kingdom,bristol,51.45,-2.583333,NCT01932593,Multiple Sclerosis,All,Stem Cells,Phase 1,6,North Bristol NHS Trust
64,france,lille,50.632971,3.058585,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Lille Catholic University
65,france,caen,49.197188,-0.326822,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier Universitaire de Caen
66,france,maubeuge,50.278499,3.974426,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier de Sambre-Avenois
67,france,raimbeaucourt,50.434656,3.093332,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hélène Borel
68,france,tourcoing,50.723907,3.161168,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier Dron de Tourcoing
69,france,douai,50.372362,3.088996,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier de Douai
70,france,amiens,49.9,2.3,NCT02008669,Multiple Sclerosis,All,Other,Phase 1,360,Centre Hospitalier Universitaire d'Amiens
71,united states of america,brookline,42.3316667,-71.1216667,NCT02649985,Multiple Sclerosis,All,Drug,Phase 1-Phase 2,50,Brigham and Women's Hospital
72,germany,darmstadt,49.870556,8.649444,NCT02064816,Multiple Sclerosis,RRMS,Drug,Phase 4,218,Merck KGaA
73,united states of america,seattle,47.6063889,-122.3308333,NCT02106052,Multiple Sclerosis,All,Other,N/A,125,University of Washington
74,switzerland,bern,46.916667,7.466667,NCT02440516,Multiple Sclerosis,All,Other,N/A,62,Department of Neurology - University Hospital Bern
75,switzerland,luzern,47.083333,8.266667,NCT02440516,Multiple Sclerosis,All,Other,N/A,62,Department of Neurology - Cantonal hospital Luzern
76,italy,ferrara,44.833333,11.583333,NCT01883310,Multiple Sclerosis,RRMS,Device,Phase 2,30,Ferrara University Hospital
77,united states of america,columbus,39.9611111,-82.9988889,NCT02258217,Multiple Sclerosis,RRMS,Drug,Phase 3,30,The Ohio State University Wexner Medical Center
78,italy,verona,45.45,11,NCT02459821,Multiple Sclerosis,All,Other,N/A,40,Azienta Ospedaliera - SSO Rehabilitation Unit - Verona
79,italy,verona,45.45,11,NCT02459821,Multiple Sclerosis,All,Other,N/A,40,prof. Smania Nicola
80,united states of america,round rock,30.5080556,-97.6786111,NCT02738775,Multiple Sclerosis,RRMS,Biological,Phase 2,40,TG Therapeutics Investigational Trial Site
81,united states of america,phoenix,33.4483333,-112.0733333,NCT02738775,Multiple Sclerosis,RRMS,Biological,Phase 2,40,TG Therapeutics Investigational Trial Site
82,united states of america,fort collins,40.5852778,-105.0838889,NCT02738775,Multiple Sclerosis,RRMS,Biological,Phase 2,40,TG Therapeutics Investigational Trial Site
83,united states of america,san antonio,29.4238889,-98.4933333,NCT02738775,Multiple Sclerosis,RRMS,Biological,Phase 2,40,TG Therapeutics Investigational Trial Site
84,france,garches,48.842257,2.182317,NCT01871818,Multiple Sclerosis,Progressive Multiple Sclerosis,Behavioral,Phase 3,240,Hôpital RAYMOND POINCARE
85,germany,muenster,51.966667,7.633333,NCT02361697,Multiple Sclerosis,CIS,Other,N/A,15,University Hospital Muenster
86,france,bordeaux,44.840439,-0.5805,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de Neurologie - Hôpital Pellegrin - CHU de Bordeaux
87,france,clermont-ferrand,45.779657,3.086281,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de neurologie - CHU de Clermont-Ferrand
88,france,dijon,47.316667,5.016667,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,CHU de Dijon
89,france,lille,50.632971,3.058585,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de Neurologie - CHRU de Lille
90,france,nancy,48.69211,6.187756,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de Neurologie - CHU de nancy
91,france,nantes,47.216509,-1.552379,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de neurologie - CHU de Nantes
92,france,strasbourg,48.600381,7.787355,NCT01442233,Multiple Sclerosis,RRMS,Other,Phase 3,80,Service de Neurologie - CHU de Strasbourg
93,united states of america,bethesda,38.9805556,-77.1005556,NCT02423083,Multiple Sclerosis,RRMS,Drug,Phase 1,12,National Institute of Neurological Disorders and Stroke (NINDS)
94,united states of america,new york,40.7141667,-74.0063889,NCT02549703,Multiple Sclerosis,All,Other,N/A,45,Icahn School of Medicine at Mount Sinai
95,united states of america,portland,45.5236111,-122.675,NCT02057159,Multiple Sclerosis,Progressive Multiple Sclerosis,Biological,Phase 2-Phase 3,200,Center Oregon Health & Science University
96,united states of america,portland,45.5236111,-122.675,NCT02200718,Multiple Sclerosis,All,Biological,Phase 1,12,Center Oregon Health & Science University
97,france,rennes,48.111981,-1.674291,NCT02652013,Multiple Sclerosis,All,Other,N/A,80,Pôle Saint Hélier
98,united states of america,aurora,39.7294444,-104.8313889,NCT01698086,Multiple Sclerosis,All,Other,N/A,88,University of Colorado Denver
99,united states of america,houston,29.7630556,-95.3630556,NCT02519244,Multiple Sclerosis,All,Device,N/A,10,The University of Texas Health Science Center - Houston
100,united states of america,portland,45.5236111,-122.675,NCT02133664,Multiple Sclerosis,All,Drug,Phase 1-Phase 2,53,Center Oregon Health & Science University
101,united states of america,phoenix,33.4483333,-112.0733333,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
102,united states of america,long beach,33.7669444,-118.1883333,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
103,united states of america,centennial,39.5791667,-104.8763889,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
104,united states of america,stamford,41.0533333,-73.5391667,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
105,united states of america,patchogue,40.7655556,-73.0155556,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
106,united states of america,charlotte,35.2269444,-80.8433333,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
107,united states of america,indian land,35.002492,-80.856553,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
108,united states of america,knoxville,35.9605556,-83.9208333,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
109,united states of america,houston,29.7630556,-95.3630556,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
110,united states of america,salt lake city,40.7608333,-111.8902778,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
111,united states of america,richmond,37.5536111,-77.4605556,NCT02634307,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Alkermes Investigational Site
112,united states of america,west orange,40.7986111,-74.2394444,NCT02301260,Multiple Sclerosis,All,Behavioral,N/A,100,Kessler Foundation
113,united states of america,new orleans,29.9544444,-90.075,NCT02011451,Multiple Sclerosis,RRMS,Drug,Phase 2,48,LSU Health Sciences Center
114,germany,berlin,52.516667,13.4,NCT02740296,Multiple Sclerosis,RRMS,Other,N/A,200,Charité - Universitätsmedizin Berlin
115,united states of america,durham,35.9938889,-78.8988889,NCT01776060,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,100,The Stedman Center on the Duke Center for Living Campus
116,united states of america,concord,35.4086111,-80.5797222,NCT01776060,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,100,NE Neurology
117,united states of america,raleigh,35.7719444,-78.6388889,NCT01776060,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,100,Raleigh Neurology Associates
118,united states of america,saint louis,38.6272222,-90.1977778,NCT02411838,Multiple Sclerosis,RRMS,Other,N/A,16,Washington University School of Medicine
119,united states of america,portland,45.5236111,-122.675,NCT01970410,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Providence Multiple Sclerosis Center
120,united states of america,phoenix,33.4483333,-112.0733333,NCT01970410,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Phoenix Neurological Associates - Ltd
121,united states of america,latham,42.7469444,-73.7594444,NCT01970410,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Multiple Sclerosis Center of Northeastern New York
122,united states of america,portland,45.5236111,-122.675,NCT01909492,Multiple Sclerosis,RRMS,Other,N/A,30,Providence Multiple Sclerosis Center
123,cayman islands,george town,19.3,-81.3833333,NCT02326935,Multiple Sclerosis,All,Stem Cells,Phase 1,100,The Da Vinci Center
124,united kingdom,sheffield,53.366667,-1.5,NCT02702804,Multiple Sclerosis,All,Other,N/A,12,Sheffield Teaching Hospitals NHS FT
125,united kingdom,sheffield,53.366667,-1.5,NCT02702804,Multiple Sclerosis,All,Other,N/A,12,Royal Hallamshire Hospital
126,israel,ramat gan,32.080556,34.814167,NCT02580435,Multiple Sclerosis,All,Other,N/A,520,Sheba Medical Center
127,united states of america,durham,35.9938889,-78.8988889,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,The Stedman Center on the Duke Center for Living Campus
128,united states of america,concord,35.4086111,-80.5797222,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,Carolinas Medical Center Northeast Medical Arts Building
129,united states of america,concord,35.4086111,-80.5797222,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,NorthEast Neurology - Concord
130,united states of america,davidson,35.4991667,-80.8488889,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,Ada Jenkins Center
131,united states of america,kannapolis,35.4872222,-80.6219444,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,Kannapolis Internal Medicine
132,united states of america,raleigh,35.7719444,-78.6388889,NCT01723709,Multiple Sclerosis,All,Other,N/A,1000,Raleigh Neurology Associates
133,germany,berlin,52.516667,13.4,NCT01371071,Multiple Sclerosis,CIS,Other,Phase 1,200,Department of Neurology - Charité - Universitätsmedizin Berlin
134,germany,berlin,52.516667,13.4,NCT01371071,Multiple Sclerosis,CIS,Other,Phase 1,200,NeuroCure Clinical Research Center - Charité - Universitätsmedizin Berlin
135,united states of america,portland,45.5236111,-122.675,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,Providence St. Vincent Medical Center
136,united states of america,cullman,34.1747222,-86.8436111,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,North Central Neurology Associates - PC
137,united states of america,medford,42.3266667,-122.8744444,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,Providence Medical Group - Medford Neurology
138,united states of america,salt lake city,40.7608333,-111.8902778,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,Rocky Mountain Research Group
139,united states of america,seattle,47.6063889,-122.3308333,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,Swedish Medical Center
140,united states of america,tacoma,47.2530556,-122.4430556,NCT02315872,Multiple Sclerosis,RRMS,Drug,Phase 3,90,MultiCare Health System -- Institute for Research and Innovation
141,united states of america,lutherville,39.4211111,-76.6263889,NCT02633033,Multiple Sclerosis,RRMS,Drug,N/A,260,Mallinckrodt Investigational Site
142,united states of america,bala-cynwyd,40.0075,-75.2344444,NCT02633033,Multiple Sclerosis,RRMS,Drug,N/A,260,Mallinckrodt Investigational Site
143,united states of america,knoxville,35.9605556,-83.9208333,NCT02633033,Multiple Sclerosis,RRMS,Drug,N/A,260,Mallinckrodt Investigational Site
144,united states of america,west orange,40.7986111,-74.2394444,NCT02496416,Multiple Sclerosis,All,Behavioral,N/A,15,Kessler Foundation
145,france,toulouse,43.599516,1.433188,NCT02403947,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,12,Purpan Hospital
146,france,rennes,48.111981,-1.674291,NCT02117375,Multiple Sclerosis,RRMS,Device,N/A,100,CHU Rennes
147,france,bordeaux,44.840439,-0.5805,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Bordeaux
148,france,caen,49.197188,-0.326822,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Caen
149,france,clermont-ferrand,45.779657,3.086281,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Clermont-Ferrand
150,france,dijon,47.316667,5.016667,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Hôpital du Bocage
151,france,dunkerque,51.05,2.366667,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CH de Dunkerque
152,france,lille,50.632971,3.058585,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Centre Hospitalier Saint Vincent de Paul
153,france,lille,50.632971,3.058585,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Hôpital Roger Salengro
154,france,marseille,43.285413,5.37606,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Marseille
155,france,montpellier,43.61092,3.87723,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU Montpellier
156,france,nancy,48.69211,6.187756,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Nancy
157,france,nice,43.713644,7.25952,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Nice
158,france,paris,48.866667,2.333333,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Hôpital Tenon
159,france,poissy,48.92902,2.049521,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,Hôpital de Poissy Saint Germain
160,france,reims,49.25,4.033333,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Reims
161,france,strasbourg,48.600381,7.787355,NCT02391064,Multiple Sclerosis,All,Behavioral,N/A,470,CHU de Strasbourg
162,united states of america,bethesda,38.9805556,-77.1005556,NCT01326715,Multiple Sclerosis,All,Drug,Phase 1,30,National Institutes of Health Clinical Center
163,sweden,stockholm,59.333333,18.05,NCT01730547,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,15,Karolinska Institute - Karolinska University Hospital Solna
164,france,nancy,48.69211,6.187756,NCT01659593,Multiple Sclerosis,All,Other,Phase 2,140,University hospital Nancy
165,canada,ottawa,45.416667,-75.7,NCT01891071,Multiple Sclerosis,All,Other,N/A,35,The Ottawa Hospital
166,canada,greenfield park,45.5,-73.483333,NCT01891071,Multiple Sclerosis,All,Other,N/A,35,Hôpital Charles-LeMoyne
167,united states of america,stratford,39.8266667,-75.0158333,NCT02227524,Multiple Sclerosis,All,Other,N/A,30,Rowan University School of Osteopathic Medicine
168,united states of america,centennial,39.5791667,-104.8763889,NCT02601885,Multiple Sclerosis,All,Drug,Phase 1,60,Site Reference ID/Investigator# 141561
169,united states of america,baltimore,39.2902778,-76.6125,NCT02601885,Multiple Sclerosis,All,Drug,Phase 1,60,Site Reference ID/Investigator# 141563
170,united states of america,boulder,40.015,-105.27,NCT02152085,Multiple Sclerosis,All,Device,N/A,30,University of Colorado
171,germany,ulm,48.4,10,NCT02671682,Multiple Sclerosis,CIS,Other,N/A,60,Department of Neurology - University of Ulm
172,germany,tubingen,48.533333,9.05,NCT02686788,Multiple Sclerosis,RRMS,Drug,Phase 2,55,UKT - Universitätsklinikum Tübingen
173,germany,frankfurt,50.116667,8.683333,NCT02686788,Multiple Sclerosis,RRMS,Drug,Phase 2,55,Goethe-Universität Frankfurt am Main
174,germany,munster,51.966667,7.633333,NCT02686788,Multiple Sclerosis,RRMS,Drug,Phase 2,55,Universitätsklinikum Münster - Klinik für Allgemeine Neurologie
175,germany,hamburg,53.55,10,NCT02686788,Multiple Sclerosis,RRMS,Drug,Phase 2,55,Universitätsklinikum Hamburg-Eppendorf - Neurologische Poliklinik - Multiple Sklerose Tagesklinik und Ambulanz
176,united states of america,bethesda,38.9805556,-77.1005556,NCT02504840,Multiple Sclerosis,CIS,Other,N/A,1300,National Institutes of Health Clinical Center
177,india,pune,18.533333,73.866667,NCT01883661,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,15,Chaitanya Hospital
178,france,lomme,50.643579,2.987148,NCT02726672,Multiple Sclerosis,All,Device,N/A,60,Hospital Group of the Catholic Institute of Lille
179,united states of america,lubbock,33.5777778,-101.8547222,NCT02418897,Multiple Sclerosis,RRMS,Behavioral,N/A,40,Texas Tech University Health Sciences Center
180,united kingdom,irvine,55.6,-4.666667,NCT02264704,Multiple Sclerosis,All,Other,N/A,63,Douglas Grant Rehabilitation Centre - Ayrshire Central Hospital
181,united states of america,birmingham,33.5205556,-86.8025,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
182,united states of america,little rock,34.7463889,-92.2894444,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
183,united states of america,los angeles,34.0522222,-118.2427778,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
184,united states of america,san francisco,37.775,-122.4183333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
185,united states of america,miami,25.7738889,-80.1938889,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
186,united states of america,orlando,28.5380556,-81.3794444,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
187,united states of america,tallahassee,30.4380556,-84.2808333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
188,united states of america,chicago,41.85,-87.65,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
189,united states of america,boston,42.3583333,-71.0602778,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
190,united states of america,boston,42.3583333,-71.0602778,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
191,united states of america,detroit,42.3313889,-83.0458333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
192,united states of america,new brunswick,40.4861111,-74.4522222,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
193,united states of america,rochester,44.0216667,-92.4697222,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
194,united states of america,stony brook,40.9255556,-73.1413889,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
195,united states of america,chapel hill,35.9130556,-79.0561111,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
196,united states of america,philadelphia,39.9522222,-75.1641667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
197,united states of america,greenville,34.8525,-82.3941667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
198,united states of america,san antonio,29.4238889,-98.4933333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
199,united states of america,salt lake city,40.7608333,-111.8902778,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
200,australia,melbourne,-37.813938,144.963425,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
201,austria,vienna,48.2,16.366667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
202,belarus,minsk,53.9,27.5666667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
203,brazil,belo horizonte,-19.916667,-43.933333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
204,brazil,rio de janeiro,-22.9,-43.233333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
205,brazil,sao paulo,-23.473293,-46.665803,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
206,brazil,goiania,-16.666667,-49.266667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
207,bulgaria,sofia,42.6833333,23.3166667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
208,canada,calgary,51.083333,-114.083333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
209,canada,ottawa,45.416667,-75.7,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
210,croatia,osijek,45.5511111,18.6938889,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
211,estonia,tallinn,59.4338889,24.7280556,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
212,france,bordeaux,44.840439,-0.5805,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
213,france,le kremlin-bicetre,48.814713,2.360728,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
214,france,marseille,43.285413,5.37606,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
215,france,montpellier,43.61092,3.87723,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
216,france,toulouse,43.599516,1.433188,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
217,germany,bochum,51.483333,7.216667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
218,germany,bonn,50.733333,7.1,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
219,germany,dresden,51.05,13.75,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
220,germany,erlangen,49.589722,11.003889,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
221,germany,essen,51.45,7.016667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
222,germany,freiburg,48,7.85,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
223,germany,gottingen,51.533333,9.933333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
224,germany,hamburg,53.55,10,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
225,germany,munich,48.15,11.5833,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
226,germany,muenster,51.966667,7.633333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
227,italy,bari,41.133333,16.85,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
228,italy,montichiari,45.416667,10.383333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
229,italy,catania,37.5,15.1,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
230,italy,milan,45.466667,9.2,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
231,italy,cefalu,38.033333,14.016667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
232,italy,rome,41.9,12.483333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
233,italy,gallarate,45.666667,8.783333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
234,italy,naples,40.833333,14.25,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
235,latvia,riga,56.95,24.1,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
236,lithuania,kaunas,54.9,23.9,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
237,mexico,mexico,19.434167,-99.138611,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
238,mexico,mexico,19.434167,-99.138611,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
239,mexico,mexico,19.434167,-99.138611,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
240,mexico,mexico,19.434167,-99.138611,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
241,netherlands,rotterdam,51.916667,4.5,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
242,poland,lodz,51.75,19.466667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
243,poland,lublin,51.25,22.566667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
244,poland,poznan,52.416667,16.966667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
245,poland,wroclaw,51.1,17.033333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
246,united states of america,santurce,18.1972222,-67.1405556,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
247,romania,bucharest,44.433333,26.1,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
248,russia,moscow,55.752222,37.615556,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
249,russia,kazan,55.78874,49.122144,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
250,russia,moscow,55.752222,37.615556,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
251,russia,novosibirsk,55.0415,82.9346,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
252,russia,saint petersburg,59.894444,30.264167,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
253,serbia,belgrade,44.818611,20.468056,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
254,serbia,kragujevac,44.016667,20.916667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
255,serbia,novi sad,45.251667,19.836944,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
256,slovakia,bratislava,48.15,17.1166667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
257,spain,malaga,36.726666,-4.434802,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
258,spain,sevilla,37.382408,-5.976133,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
259,spain,barcelona,41.398371,2.1741,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
260,spain,valencia,39.466667,-0.366667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
261,spain,bilboa,43.260919,-2.938764,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
262,spain,madrid,40.408566,-3.69222,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
263,sweden,lund,55.7,13.183333,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
264,turkey,ankara,39.911652,32.840305,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
265,turkey,ankara,39.911652,32.840305,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
266,turkey,samsun,41.286667,36.33,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
267,turkey,balcova,38.388578,27.056201,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
268,turkey,istanbul,41.018611,28.964722,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
269,turkey,konak,38.4,27.1,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
270,ukraine,cherkasy,49.428536,32.06207,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
271,ukraine,dnipropetrovsk,48.46298,35.039043,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
272,ukraine,kharkiv,49.980814,36.252718,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
273,ukraine,kharkiv,49.980814,36.252718,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
274,ukraine,kiev,50.433333,30.516667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
275,ukraine,lviv,49.840661,24.030451,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
276,ukraine,odessa,46.463934,30.738551,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
277,ukraine,vinnytsya,49.232776,28.480968,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
278,united kingdom,west midlands,52.5,-1.966667,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
279,united kingdom,edinburgh,55.95,-3.2,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
280,united kingdom,london,51.514125,-0.093689,NCT01892722,Multiple Sclerosis,RRMS,Drug,Phase 3,190,Novartis Investigative Site
281,united states of america,kenmore,47.7575,-122.2427778,NCT01703429,Multiple Sclerosis,All,Other,N/A,1000,Bastyr University Clinical Research Center
282,united states of america,cullman,34.1747222,-86.8436111,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
283,united states of america,berkeley,37.8716667,-122.2716667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
284,united states of america,carlsbad,33.1580556,-117.3497222,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
285,united states of america,pomona,34.0552778,-117.7513889,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
286,united states of america,denver,39.7391667,-104.9841667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
287,united states of america,hollywood,26.0108333,-80.1497222,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
288,united states of america,naples,26.1416667,-81.795,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
289,united states of america,ormond beach,29.2855556,-81.0561111,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
290,united states of america,tampa,27.9472222,-82.4586111,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
291,united states of america,tampa,27.9472222,-82.4586111,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
292,united states of america,northbrook,42.1275,-87.8288889,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
293,united states of america,fort wayne,41.1305556,-85.1288889,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
294,united states of america,indianapolis,39.7683333,-86.1580556,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
295,united states of america,lenexa,38.9536111,-94.7333333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
296,united states of america,saint louis,38.6272222,-90.1977778,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
297,united states of america,albuquerque,35.0844444,-106.6505556,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
298,united states of america,charlotte,35.2269444,-80.8433333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
299,united states of america,charlotte,35.2269444,-80.8433333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
300,united states of america,raleigh,35.7719444,-78.6388889,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
301,united states of america,akron,41.0813889,-81.5191667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
302,united states of america,columbus,39.9611111,-82.9988889,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
303,united states of america,dayton,39.7588889,-84.1916667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
304,united states of america,portland,45.5236111,-122.675,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
305,united states of america,franklin,35.925,-86.8688889,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
306,united states of america,knoxville,35.9605556,-83.9208333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
307,united states of america,san antonio,29.4238889,-98.4933333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
308,united states of america,orem,40.2969444,-111.6938889,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
309,united states of america,richland,46.2858333,-119.2833333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
310,argentina,buenos aires,-34.5875,-58.6725,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
311,argentina,buenos aires,-34.5875,-58.6725,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
312,argentina,buenos aires,-34.5875,-58.6725,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
313,argentina,godoy cruz,-32.928635,-68.835099,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
314,belarus,grodno,53.6813889,23.8147222,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
315,belarus,minsk,53.9,27.5666667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
316,belarus,minsk,53.9,27.5666667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
317,belarus,vitebsk,55.1925,30.1944444,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
318,belarus,vitebsk,55.1925,30.1944444,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
319,bosnia and herzegovina,sarajevo,43.85,18.3833333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
320,bosnia and herzegovina,sarajevo,43.85,18.3833333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
321,bosnia and herzegovina,tuzla,44.5427778,18.6694444,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
322,bulgaria,pleven,43.4166667,24.6166667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
323,bulgaria,plovdiv,42.15,24.75,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
324,bulgaria,sofia,42.6833333,23.3166667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
325,bulgaria,sofia,42.6833333,23.3166667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
326,bulgaria,sofia,42.6833333,23.3166667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
327,bulgaria,sofia,42.6833333,23.3166667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
328,bulgaria,sofia,42.6833333,23.3166667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
329,bulgaria,sofia,42.6833333,23.3166667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
330,bulgaria,varna,43.2166667,27.9166667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
331,canada,edmonton,53.55,-113.5,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
332,canada,victoria,48.433333,-123.35,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
333,canada,halifax,44.65,-63.6,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
334,canada,ottawa,45.416667,-75.7,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
335,canada,greenfield park,45.5,-73.483333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
336,canada,regina,50.45,-104.616667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
337,croatia,osijek,45.5511111,18.6938889,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
338,croatia,zagreb,45.8,16,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
339,croatia,zagreb,45.8,16,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
340,czech republic,brno,49.2,16.633333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
341,czech republic,brno,49.2,16.633333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
342,czech republic,hradec kralove,50.207744,15.829455,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
343,czech republic,jihlava,49.4,15.583333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
344,czech republic,ostrava,49.811852,18.255282,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
345,czech republic,pardubice,50.027778,15.775833,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
346,czech republic,prague,50.083333,14.466667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
347,czech republic,prague,50.083333,14.466667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
348,czech republic,teplice,50.646569,13.840138,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
349,finland,helsinki,60.175556,24.934167,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
350,finland,tampere,61.5,23.75,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
351,finland,turku,60.45,22.283333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
352,france,bordeaux,44.840439,-0.5805,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
353,france,clermont-ferrand,45.779657,3.086281,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
354,france,montpellier,43.61092,3.87723,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
355,france,nancy,48.69211,6.187756,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
356,france,nantes,47.216509,-1.552379,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
357,france,nice,43.713644,7.25952,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
358,france,strasbourg,48.600381,7.787355,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
359,georgia,tbilisi,41.725,44.7908333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
360,georgia,tbilisi,41.725,44.7908333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
361,georgia,tbilisi,41.725,44.7908333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
362,georgia,tbilisi,41.725,44.7908333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
363,germany,berlin,52.516667,13.4,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
364,germany,erfurt,50.983333,11.033333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
365,germany,leipzig,51.3,12.333333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
366,germany,mainz,50,8.271111,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
367,germany,ulm,48.4,10,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
368,germany,wiesbaden,50.083333,8.25,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
369,greece,athens,37.9833333,23.7333333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
370,greece,athens,37.9833333,23.7333333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
371,greece,athens,37.9833333,23.7333333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
372,greece,athens,37.9833333,23.7333333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
373,hungary,budapest,47.5,19.083333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
374,hungary,budapest,47.5,19.083333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
375,hungary,esztergom,47.7928,18.741476,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
376,hungary,gyor,47.687281,17.637616,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
377,hungary,kistarcsa,47.542839,19.263312,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
378,hungary,miskolc,48.1,20.783333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
379,israel,ashkelon,31.669256,34.57149,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
380,israel,haifa,32.815556,34.989167,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
381,israel,jerusalem,31.78,35.23,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
382,israel,petah tikwah,32.088611,34.872222,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
383,israel,rishon le zion,31.964167,34.804444,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
384,israel,safed,32.965637,35.500491,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
385,italy,cefalu,38.033333,14.016667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
386,italy,genova,44.416667,8.95,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
387,italy,l'aquila,42.366667,13.366667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
388,italy,montichiari,45.416667,10.383333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
389,italy,rome,41.9,12.483333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
390,italy,rome,41.9,12.483333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
391,latvia,riga,56.95,24.1,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
392,latvia,riga,56.95,24.1,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
393,latvia,riga,56.95,24.1,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
394,lithuania,kaunas,54.9,23.9,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
395,lithuania,klaipeda,55.7172222,21.1175,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
396,lithuania,siauliai,55.9333333,23.3166667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
397,mexico,chihuahua,28.633333,-106.083333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
398,mexico,cuauhtemoc,19.417222,-99.156944,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
399,mexico,leon,21.116667,-101.666667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
400,mexico,mexico,19.434167,-99.138611,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
401,mexico,monterrey,25.666667,-100.316667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
402,poland,bialystok,53.133333,23.15,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
403,poland,bydgoszcz,53.127062,18.019987,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
404,poland,gdansk,54.36085,18.658291,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
405,poland,katowice,50.258415,19.027545,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
406,poland,katowice,50.258415,19.027545,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
407,poland,konstancin-jeziorna,52.093277,21.118037,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
408,poland,ksawerow,51.692173,19.419126,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
409,poland,lublin,51.25,22.566667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
410,poland,lublin,51.25,22.566667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
411,poland,poznan,52.416667,16.966667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
412,poland,poznan,52.416667,16.966667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
413,poland,poznan,52.416667,16.966667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
414,poland,warsaw,52.25,21,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
415,poland,wroclaw,51.1,17.033333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
416,portugal,almada,38.679018,-9.156904,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
417,portugal,amadora,38.759711,-9.239708,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
418,portugal,braga,41.550323,-8.420052,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
419,portugal,coimbra,40.205642,-8.419551,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
420,portugal,porto,41.149606,-8.610993,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
421,romania,bucharest,44.433333,26.1,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
422,romania,bucharest,44.433333,26.1,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
423,romania,bucharest,44.433333,26.1,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
424,romania,cluj-napoca,46.766667,23.6,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
425,romania,targu-mures,46.55,24.566667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
426,romania,timisoara,45.749444,21.227222,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
427,russia,barnaul,53.360556,83.763611,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
428,russia,arkhangelsk,64.5401,40.5433,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
429,russia,belgorod,50.610743,36.580152,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
430,russia,bryansk,53.252089,34.371666,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
431,russia,ekaterinburg,56.8519,60.6122,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
432,russia,kazan,55.78874,49.122144,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
433,russia,kemerovo,55.333333,86.083333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
434,russia,kirov,58.596654,49.660068,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
435,russia,krasnoyarsk,56.0091,92.8628,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
436,russia,kursk,51.737329,36.187349,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
437,russia,moscow,55.752222,37.615556,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
438,russia,moscow,55.752222,37.615556,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
439,russia,moscow,55.752222,37.615556,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
440,russia,moscow,55.752222,37.615556,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
441,russia,nizhniy novgorod,56.326944,44.0075,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
442,russia,nizhniy novgorod,56.326944,44.0075,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
443,russia,novgorod,42.652954,130.797066,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
444,russia,novosibirsk,55.0415,82.9346,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
445,russia,novosibirsk,55.0415,82.9346,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
446,russia,penza,53.200656,45.004643,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
447,russia,perm,58.009282,56.284063,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
448,russia,pyatigorsk,44.048611,43.059444,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
449,russia,rostov-on-don,47.23135,39.723284,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
450,russia,saint petersburg,59.894444,30.264167,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
451,russia,samara,53.1835,50.1182,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
452,russia,smolensk,54.7818,32.0401,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
453,russia,saint petersburg,59.894444,30.264167,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
454,russia,saint petersburg,59.894444,30.264167,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
455,russia,saint petersburg,59.894444,30.264167,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
456,russia,saint petersburg,59.894444,30.264167,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
457,russia,tomsk,56.494167,84.974167,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
458,russia,tver,56.860491,35.876027,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
459,russia,yaroslavl,57.61977,39.85536,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
460,serbia,belgrade,44.818611,20.468056,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
461,serbia,belgrade,44.818611,20.468056,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
462,serbia,belgrade,44.818611,20.468056,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
463,serbia,kragujevac,44.016667,20.916667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
464,serbia,nis,43.324722,21.903333,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
465,spain,barcelona,41.398371,2.1741,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
466,spain,barcelona,41.398371,2.1741,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
467,spain,barcelona,41.398371,2.1741,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
468,spain,barcelona,41.398371,2.1741,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
469,spain,girona,41.984444,2.821111,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
470,spain,madrid,40.408566,-3.69222,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
471,spain,madrid,40.408566,-3.69222,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
472,spain,majadahonda,40.4717,-3.869451,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
473,spain,malaga,36.726666,-4.434802,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
474,spain,santa cruz de tenerife,28.460238,-16.280616,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
475,spain,sevilla,37.382408,-5.976133,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
476,sweden,goteborg,57.716667,11.966667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
477,sweden,stockholm,59.333333,18.05,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
478,sweden,stockholm,59.333333,18.05,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
479,turkey,istanbul,41.018611,28.964722,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
480,turkey,trabzon,41.005,39.726944,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
481,ukraine,chernihiv,51.505507,31.284875,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
482,ukraine,chernihiv,51.505507,31.284875,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
483,ukraine,ivanofrankivsk,48.921504,24.709716,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
484,ukraine,ivanofrankivsk,48.921504,24.709716,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
485,ukraine,kharkiv,49.980814,36.252718,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
486,ukraine,kharkiv,49.980814,36.252718,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
487,ukraine,kiev,50.433333,30.516667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
488,ukraine,kiev,50.433333,30.516667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
489,ukraine,lviv,49.840661,24.030451,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
490,ukraine,lviv,49.840661,24.030451,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
491,ukraine,odessa,46.463934,30.738551,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
492,ukraine,poltava,49.593727,34.540733,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
493,ukraine,ternopil,49.555887,25.605565,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
494,ukraine,vinnytsya,49.232776,28.480968,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
495,ukraine,zaporizhzhya,47.822892,35.190314,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
496,ukraine,zaporizhzhya,47.822892,35.190314,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
497,ukraine,zhytomyr,50.264868,28.676691,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
498,united kingdom,cardiff,51.5,-3.2,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
499,united kingdom,glasgow,55.833333,-4.25,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
500,united kingdom,lancashire,53.888996,-2.633778,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
501,united kingdom,salford,53.483333,-2.266667,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
502,united kingdom,staffordshire,52.833333,-2,NCT02425644,Multiple Sclerosis,RRMS,Drug,Phase 3,1100,Actelion Investigative Site
503,united states of america,boston,42.3583333,-71.0602778,NCT01353547,Multiple Sclerosis,All,Other,N/A,5000,Brigham and Womens Hospital
504,united states of america,cambridge,42.375,-71.1061111,NCT01013350,Multiple Sclerosis,All,Drug,Phase 3,1190,Outcome Sciences - Inc
505,united kingdom,glasgow,55.833333,-4.25,NCT02737904,Multiple Sclerosis,All,Other,N/A,30,Queen Elizabeth University Hospital
506,united states of america,bethesda,38.9805556,-77.1005556,NCT02659956,Multiple Sclerosis,All,Other,N/A,120,National Institutes of Health Clinical Center
507,united states of america,bethesda,38.9805556,-77.1005556,NCT00001248,Multiple Sclerosis,All,Other,N/A,920,National Institutes of Health Clinical Center
512,sweden,umea,63.833333,20.25,NCT01719159,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,30,Department of neurology - Umeå University Hospital
513,sweden,uppsala,59.85,17.633333,NCT01719159,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,30,Dept of neurology - Uppsala University Hospital
514,israel,haifa,32.815556,34.989167,NCT01954823,Multiple Sclerosis,All,Device,N/A,100,Carmel Medical Center
515,united states of america,hartford,41.7636111,-72.6855556,NCT02759211,Multiple Sclerosis,All,Other,Phase 1,16,Mandell Center for Multiple Sclerosis at the Mount Sinai Rehabilitation Hospital
516,united states of america,miami,25.7738889,-80.1938889,NCT01848327,Multiple Sclerosis,RRMS,Other,Phase 2,158,University of Miami Miller School of Medicine
517,france,lomme,50.643579,2.987148,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Groupe Hospitalier de l'Institut Catholique de Lille
518,france,bordeaux,44.840439,-0.5805,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Bordeaux
519,france,caen,49.197188,-0.326822,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire Caen
520,france,clermont-ferrand,45.779657,3.086281,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Clermont-Ferrand
521,france,dijon,47.316667,5.016667,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Dijon
522,france,lille,50.632971,3.058585,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Régional Universitaire de Lille
523,france,lyon,45.748457,4.846711,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Lyon
524,france,marseille,43.285413,5.37606,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Hopital de la Timone
525,france,nancy,48.69211,6.187756,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Universitée de Nancy
526,france,nantes,47.216509,-1.552379,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Nantes
527,france,nice,43.713644,7.25952,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Universitaire de Nice
528,france,poissy,48.92902,2.049521,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Intercommunal Poissy-St-Germain
529,france,rouen,49.433333,1.083333,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Univetrsitaire de Rouen
530,france,strasbourg,48.600381,7.787355,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier Régional Universitaire de Strasbourg
531,france,valenciennes,50.357065,3.527885,NCT02043964,Multiple Sclerosis,CIS,Other,N/A,242,Centre Hospitalier de Valenciennes
532,united states of america,bethesda,38.9805556,-77.1005556,NCT01617395,Multiple Sclerosis,All,Other,N/A,2050,National Institutes of Health Clinical Center
533,france,nimes,43.833778,4.359623,NCT02636829,Multiple Sclerosis,All,Other,N/A,100,CHRU de Nîmes - Hôpital Universitaire Carémeau
534,united kingdom,london,51.514125,-0.093689,NCT02606630,Multiple Sclerosis,RRMS,Drug,Phase 1,24,Site Reference ID/Investigator# 141463
535,united kingdom,whitechapel,51.516667,-0.05,NCT02606630,Multiple Sclerosis,RRMS,Drug,Phase 1,24,Site Reference ID/Investigator# 141461
536,france,rennes,48.111981,-1.674291,NCT01065727,Multiple Sclerosis,RRMS,Other,Phase 2,250,CHU Rennes
537,france,brest,48.390756,-4.486165,NCT01065727,Multiple Sclerosis,RRMS,Other,Phase 2,250,CHU Cavale Blanche
538,united kingdom,london,51.514125,-0.093689,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,The National hospital for Neurology and Neurosurgery - University College London
539,united kingdom,edinburgh,55.95,-3.2,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Anne Rowling Regenerative Neurology Clinic - Royal Infirmary of Edinburgh
540,united kingdom,glasgow,55.833333,-4.25,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Gartnavel Royal Hospital - 1055 Great Western Road
541,united kingdom,haywards heath,50.983333,-0.1,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Brighton and Sussex University Hospitals
542,united kingdom,leeds,53.8,-1.583333,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,St James's University Hospital
543,united kingdom,liverpool,53.416667,-3,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,The Walton Centre
544,united kingdom,newcastle,54.988056,-1.619444,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,The Royal Victoria Infirmary
545,united kingdom,nottingham,52.966667,-1.166667,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Queens Medical Centre
546,united kingdom,oxford,51.75,-1.25,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,John Radcliffe Hospital - Oxford University Hospitals NHS Trust
547,united kingdom,plymouth,50.396389,-4.138611,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Derriford Hospital
548,united kingdom,sheffield,53.366667,-1.5,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Royal Hallamshire Hospital
549,united kingdom,stoke-on-trent,53,-2.183333,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,University Hospital of North Staffordshire
550,united kingdom,truro,50.261667,-5.043333,NCT01910259,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,440,Royal Cornwall Hospital
551,france,paris,48.866667,2.333333,NCT02424396,Multiple Sclerosis,RRMS,Drug,Phase 2,30,Centre d'investigation Clinique - Pitié salpêtrière
552,france,paris,48.866667,2.333333,NCT02424396,Multiple Sclerosis,RRMS,Drug,Phase 2,30,Centre d'investigation clinique Biothérapie Immunologie (CIC-BTi) - Groupe Hospitalier Pitié-Salpêtrière - AP-HP
553,france,paris,48.866667,2.333333,NCT02424396,Multiple Sclerosis,RRMS,Drug,Phase 2,30,Département des maladies du système nerveux et Centre d'investigation clinique - Groupe Hospitalier Pitié-Salpêtrière - AP-HP
562,united states of america,chicago,41.85,-87.65,NCT00273364,Multiple Sclerosis,CIS,Stem Cells,Phase 3,110,Northwestern University - Feinberg School of Medicine
563,france,nice,43.713644,7.25952,NCT01866878,Multiple Sclerosis,All,Device,N/A,30,Hôpital Pasteur
564,united kingdom,glasgow,55.833333,-4.25,NCT02136485,Multiple Sclerosis,All,Behavioral,N/A,50,NHS Centre for Integrative Care
565,united states of america,portland,45.5236111,-122.675,NCT02583386,Multiple Sclerosis,All,Behavioral,N/A,94,VA Portland Health Care System
566,belgium,yvoir,50.333333,4.883333,NCT02266121,Multiple Sclerosis,RRMS,Device,N/A,100,Department of Neurology - CHU Dinant Godinne UcL Namur
567,chile,santiago,-33.45,-70.666667,NCT02273635,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 1-Phase 2,68,Multiple Sclerosis Centre - Pontificia Universidad Catolica de Chile
568,mexico,guadalajara,20.666667,-103.333333,NCT02769767,Multiple Sclerosis,All,Biological,N/A,500,Instituto Jalisciense de Cancerología
569,switzerland,basel,47.558395,7.573271,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,University Hospital Basel
570,switzerland,aarau,47.389616,8.052354,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,Cantonal Hospital Aarau
571,switzerland,bern,46.916667,7.466667,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,University Hospital Berne
572,switzerland,geneva,46.195602,6.148113,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,University Hospital Geneva
573,switzerland,saint gallen,47.42539,9.377615,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,Cantonal Hospital St. Gallen
574,switzerland,lugano,46.006182,8.951142,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,Regional Hospital Lugano
575,switzerland,lausanne,46.533333,6.666667,NCT02433028,Multiple Sclerosis,CIS,Other,N/A,1200,University Hospital Lausanne
576,canada,calgary,51.083333,-114.083333,NCT02087631,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,36,MS Clinic - Foothills Medical Centre  
577,united states of america,west orange,40.7986111,-74.2394444,NCT02297932,Multiple Sclerosis,All,Behavioral,N/A,20,Kessler Foundation
578,united states of america,ann arbor,42.2708333,-83.7263889,NCT02296346,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 1,66,University of Michigan Health Systems
579,iran,tehran,35.7261,51.3304,NCT02463318,Multiple Sclerosis,RRMS,Drug,Phase 2,34,Solaleh Emamgholipour
580,france,bron,45.740218,4.922415,NCT02543788,Multiple Sclerosis,All,Other,N/A,60,Unité de Neuro-Ophtalmologie - Hôpital Neurologique - HOSPICES CIVILS DE LYON
581,united states of america,gilbert,33.3527778,-111.7883333,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
582,united states of america,long beach,33.7669444,-118.1883333,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
583,united states of america,ocala,29.1869444,-82.1402778,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
584,united states of america,tampa,27.9472222,-82.4586111,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
585,united states of america,tampa,27.9472222,-82.4586111,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
586,united states of america,atlanta,33.7488889,-84.3880556,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
587,united states of america,overland park,38.9822222,-94.6705556,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
588,united states of america,baltimore,39.2902778,-76.6125,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
589,united states of america,traverse city,44.7630556,-85.6205556,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
590,united states of america,raleigh,35.7719444,-78.6388889,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
591,united states of america,spartanburg,34.9494444,-81.9322222,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
592,united states of america,san antonio,29.4238889,-98.4933333,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
593,united states of america,salt lake city,40.7608333,-111.8902778,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
594,united states of america,tacoma,47.2530556,-122.4430556,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
595,belgium,la louviere,50.466667,4.183333,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
596,bulgaria,pleven,43.4166667,24.6166667,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
597,bulgaria,pleven,43.4166667,24.6166667,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
598,bulgaria,sofia,42.6833333,23.3166667,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
599,bulgaria,sofia,42.6833333,23.3166667,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
600,croatia,vukovar,45.3433333,18.9997222,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
601,croatia,zagreb,45.8,16,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
602,lithuania,kaunas,54.9,23.9,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
603,lithuania,klaipeda,55.7172222,21.1175,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
604,lithuania,vilnius,54.6833333,25.3166667,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
605,poland,katowice,50.258415,19.027545,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
606,poland,katowice,50.258415,19.027545,NCT02525874,Multiple Sclerosis,RRMS,Drug,Phase 3,200,Biogen Investigative Site
607,united states of america,portland,45.5236111,-122.675,NCT02149706,Multiple Sclerosis,Progressive Multiple Sclerosis,Biological,Phase 2,150,OHSU MS Center
608,united states of america,baltimore,39.2902778,-76.6125,NCT02253264,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 1,12,The Johns Hopkins Hospital
609,switzerland,lugano,46.006182,8.951142,NCT02082002,Multiple Sclerosis,All,Behavioral,N/A,100,Ospedale Regionale di Lugano - Civico
610,united states of america,birmingham,33.5205556,-86.8025,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
611,united states of america,gilbert,33.3527778,-111.7883333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
612,united states of america,phoenix,33.4483333,-112.0733333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
613,united states of america,phoenix,33.4483333,-112.0733333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
614,united states of america,phoenix,33.4483333,-112.0733333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
615,united states of america,tucson,32.2216667,-110.9258333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
616,united states of america,fullerton,33.8702778,-117.9244444,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
617,united states of america,loma linda,34.0483333,-117.2602778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
618,united states of america,newport beach,33.6188889,-117.9280556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
619,united states of america,aurora,39.7294444,-104.8313889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
620,united states of america,denver,39.7391667,-104.9841667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
621,united states of america,danbury,41.3947222,-73.4544444,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
622,united states of america,dover,39.1580556,-75.5247222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
623,united states of america,newark,39.6836111,-75.75,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
624,united states of america,washington,38.895,-77.0366667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
625,united states of america,washington,38.895,-77.0366667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
626,united states of america,lighthouse point,26.2752778,-80.0875,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
627,united states of america,maitland,28.6275,-81.3633333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
628,united states of america,port charlotte,26.9758333,-82.0908333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
629,united states of america,sarasota,27.3361111,-82.5308333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
630,united states of america,saint petersburg,27.7705556,-82.6794444,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
631,united states of america,tampa,27.9472222,-82.4586111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
632,united states of america,atlanta,33.7488889,-84.3880556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
633,united states of america,augusta,33.4708333,-81.975,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
634,united states of america,savannah,32.0833333,-81.1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
635,united states of america,chicago,41.85,-87.65,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
636,united states of america,chicago,41.85,-87.65,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
637,united states of america,peoria,40.6936111,-89.5888889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
638,united states of america,winfield,41.8616667,-88.1608333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
639,united states of america,elkhart,41.6819444,-85.9766667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
640,united states of america,des moines,41.6005556,-93.6088889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
641,united states of america,des moines,41.6005556,-93.6088889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
642,united states of america,lenexa,38.9536111,-94.7333333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
643,united states of america,henderson,37.8361111,-87.59,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
644,united states of america,louisville,38.2541667,-85.7594444,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
645,united states of america,hammond,30.5041667,-90.4611111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
646,united states of america,new orleans,29.9544444,-90.075,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
647,united states of america,rockport,44.1844444,-69.0766667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
648,united states of america,baltimore,39.2902778,-76.6125,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
649,united states of america,baltimore,39.2902778,-76.6125,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
650,united states of america,glen burnie,39.1625,-76.625,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
651,united states of america,hagerstown,39.6416667,-77.7202778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
652,united states of america,rockville,39.0838889,-77.1530556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
653,united states of america,boston,42.3583333,-71.0602778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
654,united states of america,boston,42.3583333,-71.0602778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
655,united states of america,foxboro,42.0583333,-71.25,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
656,united states of america,lexington,42.4472222,-71.225,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
657,united states of america,worcester,42.2625,-71.8027778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
658,united states of america,detroit,42.3313889,-83.0458333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
659,united states of america,east lansing,42.7369444,-84.4838889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
660,united states of america,edina,44.8897222,-93.3497222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
661,united states of america,golden valley,45.0097222,-93.3488889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
662,united states of america,ocean springs,30.4111111,-88.8277778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
663,united states of america,saint louis,38.6272222,-90.1977778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
664,united states of america,lincoln,40.8,-96.6666667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
665,united states of america,lincoln,40.8,-96.6666667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
666,united states of america,las vegas,36.175,-115.1363889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
667,united states of america,flemington,40.5122222,-74.8597222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
668,united states of america,livingston,40.7958333,-74.3152778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
669,united states of america,new brunswick,40.4861111,-74.4522222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
670,united states of america,newark,40.7355556,-74.1727778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
671,united states of america,stratford,39.8266667,-75.0158333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
672,united states of america,toms river,39.9536111,-74.1983333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
673,united states of america,cedarhurst,40.6227778,-73.7247222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
674,united states of america,east meadow,40.7138889,-73.5594444,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
675,united states of america,kingston,41.9269444,-73.9977778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
676,united states of america,new york,40.7141667,-74.0063889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
677,united states of america,new york,40.7141667,-74.0063889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
678,united states of america,patchogue,40.7655556,-73.0155556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
679,united states of america,plainview,40.7763889,-73.4677778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
680,united states of america,syracuse,43.0480556,-76.1477778,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
681,united states of america,asheville,35.6008333,-82.5541667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
682,united states of america,greensboro,36.0725,-79.7922222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
683,united states of america,pinehurst,35.1952778,-79.4697222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
684,united states of america,raleigh,35.7719444,-78.6388889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
685,united states of america,bismarck,46.8083333,-100.7833333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
686,united states of america,canton,40.7988889,-81.3786111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
687,united states of america,cleveland,41.4994444,-81.6955556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
688,united states of america,oklahoma city,35.4675,-97.5161111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
689,united states of america,oklahoma city,35.4675,-97.5161111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
690,united states of america,tulsa,36.1538889,-95.9925,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
691,united states of america,portland,45.5236111,-122.675,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
692,united states of america,portland,45.5236111,-122.675,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
693,united states of america,allentown,40.6083333,-75.4905556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
694,united states of america,meadowbrook,40.1125,-75.0786111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
695,united states of america,monroeville,40.4211111,-79.7883333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
696,united states of america,philadelphia,39.9522222,-75.1641667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
697,united states of america,pittsburgh,40.4405556,-79.9961111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
698,united states of america,tarentum,40.6013889,-79.76,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
699,united states of america,willow grove,40.1438889,-75.1161111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
700,united states of america,columbia,34.0005556,-81.035,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
701,united states of america,spartanburg,34.9494444,-81.9322222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
702,united states of america,knoxville,35.9605556,-83.9208333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
703,united states of america,knoxville,35.9605556,-83.9208333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
704,united states of america,nashville,36.1658333,-86.7844444,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
705,united states of america,colleyville,32.8808333,-97.1547222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
706,united states of america,norfolk,36.8466667,-76.2855556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
707,united states of america,norfolk,36.8466667,-76.2855556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
708,united states of america,richmond,37.5536111,-77.4605556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
709,united states of america,kirkland,47.6816667,-122.2075,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
710,united states of america,seattle,47.6063889,-122.3308333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
711,united states of america,tacoma,47.2530556,-122.4430556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
712,united states of america,green bay,44.5191667,-88.0197222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
713,united states of america,green bay,44.5191667,-88.0197222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
714,united states of america,green bay,44.5191667,-88.0197222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
715,united states of america,madison,43.0730556,-89.4011111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
716,united states of america,milwaukee,43.0388889,-87.9063889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
717,united states of america,milwaukee,43.0388889,-87.9063889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
718,united states of america,neenah,44.1858333,-88.4625,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
719,australia,camperdown,-33.9,151.183333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
720,australia,concord,-33.866667,151.1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
721,australia,kogarah,-33.983333,151.116667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
722,australia,liverpool,-33.9,150.933333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
723,australia,sydney,-33.861481,151.205475,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
724,australia,new lambton,-32.933333,151.716667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
725,australia,randwick,-33.916667,151.241667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
726,australia,westmead,-33.816667,150.983333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
727,australia,brisbane,-27.47101,153.024292,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
728,australia,gold coast,-28.00029,153.430878,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
729,australia,bedford park,-35.033333,138.566667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
730,australia,adelaide,-34.928661,138.598633,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
731,australia,box hill,-37.816667,145.133333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
732,australia,clayton,-37.916667,145.116667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
733,australia,geelong,-38.153461,144.358093,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
734,australia,heidelberg,-37.75,145.066667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
735,australia,melbourne,-37.813938,144.963425,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
736,australia,melbourne,-37.813938,144.963425,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
737,australia,nedlands,-31.983333,115.808333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
738,canada,victoria,48.433333,-123.35,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
739,canada,halifax,44.65,-63.6,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
740,canada,sydney,46.15,-60.166667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
741,canada,cambridge,43.383333,-80.316667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
742,canada,london,42.983333,-81.25,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
743,canada,milton,43.516667,-79.883333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
744,canada,scarborough,43.75,-79.2,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
745,canada,thunder bay,48.4,-89.233333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
746,canada,gatineau,45.483333,-75.65,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
747,canada,montreal,45.5,-73.583333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
748,canada,regina,50.45,-104.616667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
749,czech republic,brno,49.2,16.633333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
750,czech republic,hradec kralove,50.207744,15.829455,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
751,czech republic,jihlava,49.4,15.583333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
752,czech republic,olomouc,49.59404,17.25119,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
753,czech republic,pardubice,50.027778,15.775833,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
754,czech republic,prague,50.083333,14.466667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
755,czech republic,teplice,50.646569,13.840138,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
756,denmark,aarhus,56.153423,10.22553,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
757,denmark,glostrup,55.666597,12.403768,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
758,denmark,odense,55.393475,10.394935,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
759,denmark,sonderborg,54.910634,9.792843,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
760,germany,freiburg,48,7.85,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
761,germany,heidelberg,49.416667,8.7,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
762,germany,heidenheim,48.683333,10.15,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
763,germany,ladenburg,49.475,8.606944,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
764,germany,mannheim,49.488333,8.464722,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
765,germany,ravensburg,47.783333,9.616667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
766,germany,singen,47.766667,8.833333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
767,germany,sinsheim,49.255278,8.877222,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
768,germany,stuttgart,48.766667,9.183333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
769,germany,stuttgart,48.766667,9.183333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
770,germany,ulm,48.4,10,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
771,germany,bogen,48.916667,12.683333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
772,germany,erlangen,49.589722,11.003889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
773,germany,landshut,48.533333,12.15,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
774,germany,munich,48.15,11.5833,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
775,germany,neuburg,49.346667,12.384444,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
776,germany,neusass,48.4,10.833333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
777,germany,nurnberg,49.447778,11.068333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
778,germany,nurnberg,49.447778,11.068333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
779,germany,regensburg,49.015,12.095556,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
780,germany,unterhaching,48.05,11.633333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
781,germany,wolfratshausen,47.916667,11.416667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
782,germany,wurzburg,49.787778,9.936111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
783,germany,butzbach,50.433333,8.683333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
784,germany,eltville,50.033333,8.116667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
785,germany,erbach,49.656111,8.996389,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
786,germany,eschwege,51.183333,10.066667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
787,germany,frankfurt,50.116667,8.683333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
788,germany,frankfurt,50.116667,8.683333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
789,germany,frankfurt,50.116667,8.683333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
790,germany,gelnhausen,50.2,9.183333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
791,germany,gladenbach,50.766667,8.566667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
792,germany,kassel,51.316667,9.5,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
793,germany,wiesbaden,50.083333,8.25,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
794,germany,buchholz,53.416667,9.433333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
795,germany,gottingen,51.533333,9.933333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
796,germany,oldenburg,53.166667,8.2,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
797,germany,aachen,50.770833,6.105278,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
798,germany,aachen,50.770833,6.105278,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
799,germany,honnef,50.633333,7.233333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
800,germany,bergisch gladbach,50.983333,7.133333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
801,germany,bielefeld,52.033333,8.533333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
802,germany,bochum,51.483333,7.216667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
803,germany,bonn,50.733333,7.1,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
804,germany,dusseldorf,51.216667,6.766667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
805,germany,essen,51.45,7.016667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
806,germany,hagen,51.35,7.466667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
807,germany,koln,50.933333,6.95,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
808,germany,koln,50.933333,6.95,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
809,germany,siegen,50.866667,8.033333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
810,germany,willich,51.266667,6.55,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
811,germany,wuppertal,51.266667,7.183333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
812,germany,kandel,49.089167,8.184167,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
813,germany,katzenelnbogen,50.283333,7.95,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
814,germany,trier,49.75,6.633333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
815,germany,halle,51.5,12,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
816,germany,magdeburg,52.166667,11.666667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
817,germany,chemnitz,50.833333,12.916667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
818,germany,goerlitz,51.166667,15,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
819,germany,leipzig,51.3,12.333333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
820,germany,wermsdorf,51.283333,12.95,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
821,germany,kiel,54.333333,10.133333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
822,germany,eisenach,50.983333,10.316667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
823,germany,jena,50.933333,11.583333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
824,germany,berlin,52.516667,13.4,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
825,germany,berlin,52.516667,13.4,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
826,germany,berlin,52.516667,13.4,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
827,germany,berlin,52.516667,13.4,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
828,germany,berlin,52.516667,13.4,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
829,germany,hamburg,53.55,10,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
830,hungary,budapest,47.5,19.083333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
831,hungary,budapest,47.5,19.083333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
832,hungary,eger,47.9,20.383333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
833,hungary,esztergom,47.7928,18.741476,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
834,netherlands,amsterdam,52.35,4.916667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
835,netherlands,breda,51.566667,4.8,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
836,netherlands,eindhoven,51.45,5.466667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
837,netherlands,leeuwarden,53.20139,5.808588,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
838,netherlands,leiden,52.176281,4.528154,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
839,netherlands,geleen,50.965741,5.834752,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
840,netherlands,tilburg,51.576922,5.106331,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
841,netherlands,venray,51.524517,5.975006,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
842,norway,bodo,67.283333,14.383333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
843,norway,namsos,64.483333,11.5,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
844,united states of america,guaynabo,18.3594444,-66.1113889,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
845,united states of america,san juan,18.4683333,-66.1061111,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
846,slovakia,banska bystrica,48.7333333,19.15,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
847,slovakia,nitra,48.3166667,18.0833333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
848,slovakia,ruzomberok,49.0833333,19.3166667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
849,united kingdom,bristol,51.45,-2.583333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
850,united kingdom,portadown,54.433333,-6.45,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
851,united kingdom,exeter,50.7,-3.533333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
852,united kingdom,plymouth,50.396389,-4.138611,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
853,united kingdom,torquay,50.45,-3.5,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
854,united kingdom,salford,53.483333,-2.266667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
855,united kingdom,basingstoke,51.266667,-1.083333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
856,united kingdom,leicester,52.633333,-1.133333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
857,united kingdom,edinburgh,55.95,-3.2,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
858,united kingdom,liverpool,53.416667,-3,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
859,united kingdom,norwich,52.633333,1.3,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
860,united kingdom,nottingham,52.966667,-1.166667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
861,united kingdom,glasgow,55.833333,-4.25,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
862,united kingdom,dundee,56.5,-2.966667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
863,united kingdom,newcastle,54.988056,-1.619444,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
864,united kingdom,birmingham,52.466667,-1.916667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
865,united kingdom,leeds,53.8,-1.583333,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
866,united kingdom,swansea,51.633333,-3.966667,NCT02047097,Multiple Sclerosis,All,Drug,Phase 4,5000,Biogen Investigative Site
867,united states of america,cleveland,41.4994444,-81.6955556,NCT01572714,Multiple Sclerosis,All,Behavioral,Phase 1,215,Case Western Reserve University
868,belgium,diepenbeek,50.9,5.4,NCT02339675,Multiple Sclerosis,All,Other,N/A,300,Hasselt University
869,canada,vancouver,49.25,-123.133333,NCT01118130,Multiple Sclerosis,RRMS,Other,N/A,300,MS Clinic UBC Hospital
870,canada,halifax,44.65,-63.6,NCT01118130,Multiple Sclerosis,RRMS,Other,N/A,300,Dalhousie MS Research Unit
871,canada,london,42.983333,-81.25,NCT01118130,Multiple Sclerosis,RRMS,Other,N/A,300,London Health Sciences Centre MS clinic  
872,canada,montreal,45.5,-73.583333,NCT01118130,Multiple Sclerosis,RRMS,Other,N/A,300,Hôpital Notre-Dame MS clinic
873,canada,gatineau,45.483333,-75.65,NCT02383550,Multiple Sclerosis,All,Other,Phase 4,47,Clinique Neuro-Outaouais
874,canada,montreal,45.5,-73.583333,NCT02137707,Multiple Sclerosis,RRMS,Drug,Phase 4,400,Montreal Neurological Institute
875,canada,edmonton,53.55,-113.5,NCT02137707,Multiple Sclerosis,RRMS,Drug,Phase 4,400,University of Alberta
876,canada,vancouver,49.25,-123.133333,NCT02137707,Multiple Sclerosis,RRMS,Drug,Phase 4,400,University of British Columbia
877,canada,ottawa,45.416667,-75.7,NCT02137707,Multiple Sclerosis,RRMS,Drug,Phase 4,400,Ottawa General Hospital
878,united states of america,west orange,40.7986111,-74.2394444,NCT02301247,Multiple Sclerosis,All,Behavioral,N/A,48,Kessler Foundation
879,united states of america,kirkland,47.6816667,-122.2075,NCT02086188,Multiple Sclerosis,All,Drug,Phase 4,40,EvergreenHealth MS Center
880,denmark,aarhus,56.153423,10.22553,NCT02661555,Multiple Sclerosis,All,Other,N/A,85,Sport Science - Department of Public Health - Aarhus University
881,france,lille,50.632971,3.058585,NCT02468765,Multiple Sclerosis,RRMS,Other,N/A,90,Hôpital Saint Vincent de Paul (GHICL)
882,united states of america,maitland,28.6275,-81.3633333,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
883,united states of america,reston,38.9686111,-77.3413889,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
884,australia,box hill,-37.816667,145.133333,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
885,germany,bochum,51.483333,7.216667,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
886,ireland,dublin,53.3330556,-6.2488889,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
887,italy,firenze,43.766667,11.25,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
888,spain,malaga,36.726666,-4.434802,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
889,united kingdom,salford,53.483333,-2.266667,NCT01911767,Multiple Sclerosis,All,Drug,N/A,750,Biogen Investigative Site
890,germany,berlin,52.516667,13.4,NCT01790269,Multiple Sclerosis,RRMS,Other,Phase 1,40,Charité Universitätsmedizin Berlin
891,united states of america,portland,45.5236111,-122.675,NCT02424825,Multiple Sclerosis,All,Behavioral,N/A,15,Oregon Health & Science University Multiple Sclerosis Center
892,belgium,hasselt,50.933333,5.333333,NCT02466165,Multiple Sclerosis,All,Behavioral,N/A,100,Jessa hospital
893,belgium,diepenbeek,50.9,5.4,NCT02466165,Multiple Sclerosis,All,Behavioral,N/A,100,REVAL
894,united states of america,baltimore,39.2902778,-76.6125,NCT02647502,Multiple Sclerosis,RRMS,Other,Phase 1,36,Johns Hopkins University
895,united states of america,west orange,40.7986111,-74.2394444,NCT02081508,Multiple Sclerosis,All,Behavioral,N/A,72,Kessler Foundation
896,united kingdom,edinburgh,55.95,-3.2,NCT02508961,Multiple Sclerosis,All,Behavioral,N/A,90,Anne Rowling Regenerative Neurology Clinic
897,united kingdom,irvine,55.6,-4.666667,NCT02508961,Multiple Sclerosis,All,Behavioral,N/A,90,Douglas Grant Rehabilitation Centre
898,united kingdom,plymouth,50.396389,-4.138611,NCT02508961,Multiple Sclerosis,All,Behavioral,N/A,90,University of Plymouth
899,israel,jerusalem,31.78,35.23,NCT02166021,Multiple Sclerosis,Progressive Multiple Sclerosis,Stem Cells,Phase 2,36,Hadassah Medical Center
900,france,nice,43.713644,7.25952,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Nice
901,france,besancon,47.248778,6.018152,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Besançon
902,france,lille,50.632971,3.058585,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Lille
903,france,montpellier,43.61092,3.87723,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Montpellier
904,france,strasbourg,48.600381,7.787355,NCT02587195,Multiple Sclerosis,All,Drug,Phase 3,11,CHU de Strasbourg
905,canada,calgary,51.083333,-114.083333,NCT02308137,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,62,Calgary MS Clinic at Foothills Medical Centre
906,united kingdom,london,51.514125,-0.093689,NCT02104661,Multiple Sclerosis,All,Drug,Phase 2,60,Barts Health NHS Trust
907,united states of america,aurora,39.7294444,-104.8313889,NCT02588053,Multiple Sclerosis,RRMS,Drug,Phase 4,146,University of Colorado Anschutz
908,italy,ciserano,45.583333,9.6,NCT02291107,Multiple Sclerosis,All,Device,N/A,17,HABILITA
909,spain,cordoba,37.89155,-4.772748,NCT01745783,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,30,University Hospital Reina Sofia
910,spain,malaga,36.726666,-4.434802,NCT01745783,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,30,University Regional Hospital Carlos Haya
911,spain,sevilla,37.382408,-5.976133,NCT01745783,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,30,University Hospital Virgen Macarena
912,united states of america,urbana,40.1105556,-88.2072222,NCT02274935,Multiple Sclerosis,All,Other,N/A,30,Motor control research lab
913,united states of america,baltimore,39.2902778,-76.6125,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Johns Hopkins University School of Medicine
914,united states of america,san francisco,37.775,-122.4183333,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of California - San Francisco
915,united states of america,stanford,37.4241667,-122.165,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Stanford University
916,united states of america,new haven,41.3080556,-72.9286111,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Yale University
917,united states of america,annapolis,38.9783333,-76.4925,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Anne Arundel Health System Research Institute
918,united states of america,worcester,42.2625,-71.8027778,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of Massachusetts
919,united states of america,saint louis,38.6272222,-90.1977778,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Washington University St. Louis
920,united states of america,new york,40.7141667,-74.0063889,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Mount Sinai School of Medicine
921,united states of america,new york,40.7141667,-74.0063889,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Columbia University
922,united states of america,rochester,44.0216667,-92.4697222,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of Rochester
923,united states of america,cleveland,41.4994444,-81.6955556,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Cleveland Clinic
924,united states of america,portland,45.5236111,-122.675,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Oregon Health Sciences University
925,united states of america,philadelphia,39.9522222,-75.1641667,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of Pennsylvania
926,united states of america,charlottesville,38.0291667,-78.4769444,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,University of Virginia
927,united states of america,seattle,47.6063889,-122.3308333,NCT01490502,Multiple Sclerosis,RRMS,Drug,Phase 3,172,Swedish Medical Center
928,germany,rostock,54.083333,12.133333,NCT02275741,Multiple Sclerosis,RRMS,Biological,Phase 2,400,University of Rostock
929,germany,berlin,52.516667,13.4,NCT02509897,Multiple Sclerosis,RRMS,Other,N/A,48,Experimental & Clinical Research Center
930,united states of america,chicago,41.85,-87.65,NCT01824550,Multiple Sclerosis,All,Other,N/A,54,University of Illinois at Chicago
931,united states of america,new york,40.7141667,-74.0063889,NCT02746705,Multiple Sclerosis,All,Device,Phase 3,60,New York University Langone Medical Center
932,belgium,diepenbeek,50.9,5.4,NCT02339688,Multiple Sclerosis,All,Other,N/A,300,Hasselt University
933,united states of america,long beach,33.7669444,-118.1883333,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #12
934,united states of america,sacramento,38.5816667,-121.4933333,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #3
935,united states of america,san francisco,37.775,-122.4183333,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #7
936,united states of america,stanford,37.4241667,-122.165,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #15
937,united states of america,aurora,39.7294444,-104.8313889,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #11
938,united states of america,centennial,39.5791667,-104.8763889,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #16
939,united states of america,saint louis,38.6272222,-90.1977778,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #14
940,united states of america,teaneck,40.8975,-74.0163889,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #19
941,united states of america,rochester,44.0216667,-92.4697222,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #10
942,united states of america,dallas,32.7833333,-96.8,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #18
943,united states of america,seattle,47.6063889,-122.3308333,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #2
944,united states of america,seattle,47.6063889,-122.3308333,NCT02398461,Multiple Sclerosis,RRMS,Drug,Phase 1,30,Acorda Site #6
945,australia,east gosford,-33.433333,151.35,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
946,australia,kanwal,-33.266667,151.483333,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
947,australia,liverpool,-33.9,150.933333,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
948,australia,new lambton,-32.933333,151.716667,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
949,australia,sydney,-33.861481,151.205475,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
950,australia,brisbane,-27.47101,153.024292,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
951,australia,adelaide,-34.928661,138.598633,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
952,australia,box hill,-37.816667,145.133333,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
953,australia,fitzroy,-37.783333,144.983333,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
954,australia,fitzroy,-37.783333,144.983333,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
955,australia,melbourne,-37.813938,144.963425,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
956,australia,melbourne,-37.813938,144.963425,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
957,australia,nedlands,-31.983333,115.808333,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
958,australia,bedford park,-35.033333,138.566667,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
959,australia,brisbane,-27.47101,153.024292,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
960,australia,geelong,-38.153461,144.358093,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
961,spain,ferrol,43.483213,-8.236893,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
962,spain,cordoba,37.89155,-4.772748,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
963,spain,granada,37.178354,-3.599201,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
964,spain,malaga,36.726666,-4.434802,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
965,spain,sevilla,37.382408,-5.976133,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
966,spain,sevilla,37.382408,-5.976133,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
967,spain,oviedo,43.363223,-5.853128,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
968,spain,santander,43.464722,-3.804444,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
969,spain,albacete,38.995845,-1.857773,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
970,spain,valladolid,41.655181,-4.72372,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
971,spain,leon,42.600031,-5.570316,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
972,spain,badalona,41.447145,2.244789,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
973,spain,barcelona,41.398371,2.1741,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
974,spain,barcelona,41.398371,2.1741,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
975,spain,tarragona,41.116667,1.25,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
976,spain,valencia,39.466667,-0.366667,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
977,spain,valencia,39.466667,-0.366667,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
978,spain,valencia,39.466667,-0.366667,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
979,spain,la coruna,43.366609,-8.406812,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
980,spain,palma de mallorca,39.574337,2.655222,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
981,spain,las palmas de gran canaria,28.099727,-15.41343,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
982,spain,pamplona,42.814075,-1.641153,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
983,spain,bilboa,43.260919,-2.938764,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
984,spain,bilboa,43.260919,-2.938764,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
985,spain,barcelona,41.398371,2.1741,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
986,spain,las palmas de gran canaria,28.099727,-15.41343,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
987,spain,madrid,40.408566,-3.69222,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
988,spain,madrid,40.408566,-3.69222,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
989,spain,madrid,40.408566,-3.69222,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
990,spain,madrid,40.408566,-3.69222,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
991,spain,madrid,40.408566,-3.69222,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
992,spain,santa cruz de tenerife,28.460238,-16.280616,NCT01498887,Multiple Sclerosis,RRMS,Drug,Phase 4,434,Novartis Investigative Site
993,united states of america,baltimore,39.2902778,-76.6125,NCT01647321,Multiple Sclerosis,Progressive Multiple Sclerosis,Behavioral,Phase 1,20,Kennedy Krieger Institute / Johns Hopkins
994,united states of america,san bernardino,34.1083333,-117.2888889,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
995,belgium,ghent,51.05,3.716667,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
996,bulgaria,sofia,42.6833333,23.3166667,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
997,czech republic,hradec kralove,50.207744,15.829455,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
998,germany,munich,48.15,11.5833,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
999,germany,gottingen,51.533333,9.933333,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1000,kuwait,kuwait,29.369722,47.978333,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1001,latvia,riga,56.95,24.1,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1002,lebanon,beirut,33.8719444,35.5097222,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1003,poland,gdansk,54.36085,18.658291,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1004,poland,poznan,52.416667,16.966667,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1005,turkey,ankara,39.911652,32.840305,NCT02555215,Multiple Sclerosis,RRMS,Drug,Phase 3,20,Biogen Investigative Site
1006,france,paris,48.866667,2.333333,NCT01651520,Multiple Sclerosis,RRMS,Drug,N/A,80,Pitié Salpêtrière Hospital
1007,united states of america,new haven,41.3080556,-72.9286111,NCT02282878,Multiple Sclerosis,All,Other,N/A,25,Yale MS Center
1008,united states of america,cleveland,41.4994444,-81.6955556,NCT02391961,Multiple Sclerosis,All,Drug,Phase 2,30,Louis Stokes VA Medical Center - Cleveland - OH
1009,united kingdom,cambridge,52.2,0.116667,NCT01712945,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,86,Addenbrooke's Hospital
1010,france,bordeaux,44.840439,-0.5805,NCT02290587,Multiple Sclerosis,RRMS,Other,N/A,35,CHU de Bordeaux
1011,italy,pavia,45.166667,9.166667,NCT02331654,Multiple Sclerosis,All,Other,N/A,60,IRCCS Fondazione Istituto Neurologico Nazionale C. Mondino
1012,belgium,brussels,50.833333,4.333333,NCT02607020,Multiple Sclerosis,All,Other,N/A,100,Cliniques universitaires Saint-Luc
1013,france,bordeaux,44.840439,-0.5805,NCT02708927,Multiple Sclerosis,RRMS,Other,N/A,90,CHU de Bordeaux
1014,france,dijon,47.316667,5.016667,NCT02708927,Multiple Sclerosis,RRMS,Other,N/A,90,CHU de Dijon
1015,belgium,liege,50.633333,5.566667,NCT02427776,Multiple Sclerosis,RRMS,Stem Cells,Phase 1-Phase 2,18,University Hospital of Liège
1016,belgium,brussels,50.833333,4.333333,NCT02427776,Multiple Sclerosis,RRMS,Stem Cells,Phase 1-Phase 2,18,Cliniques universitaires Saint-Luc
1017,belgium,leuven,50.883333,4.7,NCT02427776,Multiple Sclerosis,RRMS,Stem Cells,Phase 1-Phase 2,18,University Hospital Leuven (Gasthuisberg)
1018,france,caen,49.197188,-0.326822,NCT01805336,Multiple Sclerosis,RRMS,Other,N/A,60,Department of Neurologie - Caen Hospital University
1019,france,caen,49.197188,-0.326822,NCT01805336,Multiple Sclerosis,RRMS,Other,N/A,60,Inserm Unit 1075 Comete - Caen Hospital University
1020,united kingdom,edinburgh,55.95,-3.2,NCT01914016,Multiple Sclerosis,All,Other,N/A,10,Slateford medical centre
1021,italy,ferrara,44.833333,11.583333,NCT02421731,Multiple Sclerosis,All,Device,Phase 2,98,Ferrara University Hospital
1022,italy,ferrara,44.833333,11.583333,NCT02421731,Multiple Sclerosis,All,Device,Phase 2,98,Ferrara University Hospital
1023,united states of america,aventura,25.9561111,-80.1394444,NCT01453764,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,50,Ageless Regenerative Institute LLC
1024,israel,jerusalem,31.78,35.23,NCT02529839,Multiple Sclerosis,All,Stem Cells,N/A,20,Hadassah University Hospital
1025,united kingdom,london,51.514125,-0.093689,NCT02542787,Multiple Sclerosis,All,Drug,Phase 2,160,The National Hospital for Neurology and Neurosurgery
1026,united kingdom,liverpool,53.416667,-3,NCT02542787,Multiple Sclerosis,All,Drug,Phase 2,160,The Neuroscience Research Centre - The Walton Centre NHS Foundation Trust
1027,united kingdom,london,51.514125,-0.093689,NCT02542787,Multiple Sclerosis,All,Drug,Phase 2,160,The Royal London Hospital
1028,united kingdom,sheffield,53.366667,-1.5,NCT02542787,Multiple Sclerosis,All,Drug,Phase 2,160,Royal Hallamshire Hospital - Sheffield Teaching Hospital NHS Foundation Trust
1029,united states of america,jonesboro,35.8422222,-90.7041667,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1030,united states of america,carmichael,38.6172222,-121.3272222,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1031,united states of america,la jolla,32.8472222,-117.2733333,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1032,united states of america,la mesa,32.7677778,-117.0222222,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1033,united states of america,pomona,34.0552778,-117.7513889,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1034,united states of america,simi valley,34.2694444,-118.7805556,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1035,united states of america,aurora,39.7294444,-104.8313889,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1036,united states of america,colorado springs,38.8338889,-104.8208333,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1037,united states of america,fairfield,41.1411111,-73.2641667,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1038,united states of america,washington,38.895,-77.0366667,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1039,united states of america,jacksonville,30.3319444,-81.6558333,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1040,united states of america,naples,26.1416667,-81.795,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1041,united states of america,ormond beach,29.2855556,-81.0561111,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1042,united states of america,sunrise,26.1336111,-80.1133333,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1043,united states of america,rome,34.2569444,-85.1647222,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1044,united states of america,chicago,41.85,-87.65,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1045,united states of america,flossmoor,41.5427778,-87.6847222,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1046,united states of america,indianapolis,39.7683333,-86.1580556,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1047,united states of america,louisville,38.2541667,-85.7594444,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1048,united states of america,scarborough,43.5780556,-70.3222222,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1049,united states of america,farmington hills,42.4852778,-83.3772222,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1050,united states of america,chesterfield,38.6630556,-90.5769444,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1051,united states of america,kansas city,39.0997222,-94.5783333,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1052,united states of america,saint louis,38.6272222,-90.1977778,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1053,united states of america,freehold,40.26,-74.2741667,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1054,united states of america,amherst,42.9783333,-78.8,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1055,united states of america,new york,40.7141667,-74.0063889,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1056,united states of america,patchogue,40.7655556,-73.0155556,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1057,united states of america,hendersonville,35.3186111,-82.4611111,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1058,united states of america,raleigh,35.7719444,-78.6388889,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1059,united states of america,sanford,35.4797222,-79.1805556,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1060,united states of america,winston-salem,36.0997222,-80.2444444,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1061,united states of america,dayton,39.7588889,-84.1916667,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1062,united states of america,dayton,39.7588889,-84.1916667,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1063,united states of america,uniontown,40.975,-81.4083333,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1064,united states of america,oklahoma city,35.4675,-97.5161111,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1065,united states of america,portland,45.5236111,-122.675,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1066,united states of america,tualatin,45.3841667,-122.7627778,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1067,united states of america,dickson city,41.4713889,-75.6080556,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1068,united states of america,greensburg,40.3013889,-79.5391667,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1069,united states of america,hershey,40.2858333,-76.6505556,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1070,united states of america,wilkes-barre,41.2458333,-75.8816667,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1071,united states of america,nashville,36.1658333,-86.7844444,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1072,united states of america,dallas,32.7833333,-96.8,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1073,united states of america,round rock,30.5080556,-97.6786111,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1074,united states of america,alexandria,38.8047222,-77.0472222,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1075,united states of america,newport news,36.9786111,-76.4283333,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1076,united states of america,seattle,47.6063889,-122.3308333,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1077,united states of america,madison,43.0730556,-89.4011111,NCT02410278,Multiple Sclerosis,RRMS,Drug,Phase 4,295,Biogen Investigative Site
1078,turkey,ankara,39.911652,32.840305,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1079,turkey,bursa,40.191667,29.061111,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1080,turkey,istanbul,41.018611,28.964722,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1081,turkey,istanbul,41.018611,28.964722,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1082,turkey,kocaeli,40.766944,29.916944,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1083,turkey,kutahya,39.424167,29.983333,NCT02575365,Multiple Sclerosis,RRMS,Drug,Phase 4,120,Novartis Investigative Site  
1084,united states of america,buffalo,42.8863889,-78.8786111,NCT02651545,Multiple Sclerosis,RRMS,Drug,Phase 4,60,Buffalo General Hospital
1085,spain,barcelona,41.398371,2.1741,NCT02283671,Multiple Sclerosis,All,Drug,Phase 1,12,Hospital Clinic of Barcelona
1086,united states of america,minneapolis,44.98,-93.2636111,NCT01950234,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,100,Clinical Neuroscience Research Unit - University of Minnesota
1087,united states of america,fargo,46.8772222,-96.7894444,NCT01950234,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,100,Sanford Clinic Neuroscience
1088,united states of america,oklahoma city,35.4675,-97.5161111,NCT01950234,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,100,Oklahoma Medical Research Foundation Multiple Sclerosis Center of Excellence
1089,united states of america,milwaukee,43.0388889,-87.9063889,NCT01950234,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,100,Wheaton Franciscan Healthcare - St Francis Center for Neurological Disorders
1090,united states of america,cullman,34.1747222,-86.8436111,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1091,united states of america,boston,42.3583333,-71.0602778,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1092,united states of america,raleigh,35.7719444,-78.6388889,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1093,australia,melbourne,-37.813938,144.963425,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1094,belgium,gent,51.05,3.716667,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1095,belgium,leuven,50.883333,4.7,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1096,canada,calgary,51.083333,-114.083333,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1097,estonia,tallinn,59.4338889,24.7280556,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1098,france,le kremlin-bicetre,48.814713,2.360728,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1099,france,lyon,45.748457,4.846711,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1100,france,marseille,43.285413,5.37606,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1101,france,rennes,48.111981,-1.674291,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1102,greece,thessaloniki,40.6402778,22.9438889,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1103,israel,jerusalem,31.78,35.23,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1104,israel,tel hashomer,32.053889,34.848056,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1105,israel,tel aviv,32.066667,34.766667,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1106,israel,ness ziona,31.926389,34.803333,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1107,lebanon,beirut,33.8719444,35.5097222,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1108,lithuania,kaunas,54.9,23.9,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1109,russia,moscow,55.752222,37.615556,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1110,russia,nizhniy novgorod,56.326944,44.0075,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1111,russia,novosibirsk,55.0415,82.9346,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1112,russia,saint petersburg,59.894444,30.264167,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1113,russia,saint petersburg,59.894444,30.264167,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1114,spain,madrid,40.408566,-3.69222,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1115,spain,murcia,37.987041,-1.130042,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1116,spain,sevilla,37.382408,-5.976133,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1117,turkey,ankara,39.911652,32.840305,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1118,turkey,ankara,39.911652,32.840305,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1119,turkey,istanbul,41.018611,28.964722,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1120,turkey,istanbul,41.018611,28.964722,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1121,turkey,istanbul,41.018611,28.964722,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1122,turkey,izmir,38.412726,27.138376,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1123,turkey,izmir,38.412726,27.138376,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1124,turkey,trabzon,41.005,39.726944,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1125,united kingdom,birmingham,52.466667,-1.916667,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1126,united kingdom,london,51.514125,-0.093689,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1127,united kingdom,london,51.514125,-0.093689,NCT02201108,Multiple Sclerosis,RRMS,Drug,Phase 3,165,Genzyme Investigative Site  
1128,norway,bodo,67.283333,14.383333,NCT02522962,Multiple Sclerosis,All,Behavioral,Phase 4,72,Physiotherapy department - Nordlandssykehuset HF
1129,austria,vienna,48.2,16.366667,NCT01879202,Multiple Sclerosis,All,Drug,Phase 2,96,Medical University of Vienna - Department of Neurology
1130,united states of america,stony brook,40.9255556,-73.1413889,NCT02606604,Multiple Sclerosis,All,Device,N/A,20,Stony Brook Univeristy
1131,israel,haifa,32.815556,34.989167,NCT02488343,Multiple Sclerosis,All,Behavioral,N/A,400,MS Clinic - Carmel Medical Center
1132,israel,tel hashomer,32.053889,34.848056,NCT02259361,Multiple Sclerosis,All,Drug,Phase 4,30,Multiple Sclerosis Center
1133,united states of america,el paso,31.7586111,-106.4863889,NCT02694666,Multiple Sclerosis,All,Device,N/A,440,Stanley E. Fulton Biomechanics Laboratory
1134,united states of america,la jolla,32.8472222,-117.2733333,NCT02157064,Multiple Sclerosis,All,Stem Cells,N/A,100,StemGenex
1135,united states of america,fresno,36.7477778,-119.7713889,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Victoria Walton - MD
1136,united states of america,fullerton,33.8702778,-117.9244444,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Fullerton Neurology and Headache Center
1137,united states of america,newport beach,33.6188889,-117.9280556,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Multiple Sclerosis Center of California & Research
1138,united states of america,sacramento,38.5816667,-121.4933333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Sutter Institute for Medical Research
1139,united states of america,san francisco,37.775,-122.4183333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of California San Francisco
1140,united states of america,temecula,33.4936111,-117.1475,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Viking Clinical Research Center
1141,united states of america,englewood,39.6477778,-104.9872222,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Colorado Neurological Institute
1142,united states of america,newark,39.6836111,-75.75,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Christiana Care Health Services
1143,united states of america,bradenton,27.4986111,-82.575,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Brandenton Neurology - Inc.
1144,united states of america,hollywood,26.0108333,-80.1497222,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Sunrise Clinical Research - Inc.
1145,united states of america,jacksonville,30.3319444,-81.6558333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Florida
1146,united states of america,maitland,28.6275,-81.3633333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurology Associates - PA
1147,united states of america,ormond beach,29.2855556,-81.0561111,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurology Associates of Ormond Beach
1148,united states of america,pompano beach,26.2375,-80.125,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurological Associates
1149,united states of america,port orange,29.1380556,-80.9958333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Progressive Medical Research
1150,united states of america,sarasota,27.3361111,-82.5308333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Roskamp Institute
1151,united states of america,saint petersburg,27.7705556,-82.6794444,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Suncoast Neuroscience Associates - Inc
1152,united states of america,tallahassee,30.4380556,-84.2808333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,AMO Corporation
1153,united states of america,vero beach,27.6383333,-80.3975,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,MS Center of Vero Beach
1154,united states of america,weston,26.1,-80.4,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Cleveland Clinic Florida
1155,united states of america,decatur,33.7747222,-84.2963889,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurostudies
1156,united states of america,honolulu,21.3069444,-157.8583333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Leo Maher - MD
1157,united states of america,flossmoor,41.5427778,-87.6847222,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,South Suburban Neurology
1158,united states of america,merrillville,41.4827778,-87.3327778,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neuroscience Institute
1159,united states of america,des moines,41.6005556,-93.6088889,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Mercy Ruan Neurology Clinic Res Ct.
1160,united states of america,lenexa,38.9536111,-94.7333333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Mid America Neuroscience Institute
1161,united states of america,topeka,39.0483333,-95.6777778,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Precise Clinical Research
1162,united states of america,topeka,39.0483333,-95.6777778,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Cotton O'Neil Clinical Research Institute
1163,united states of america,lexington,37.9886111,-84.4777778,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Associates in Neurology
1164,united states of america,louisville,38.2541667,-85.7594444,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Norton Healthcare - Inc.
1165,united states of america,baltimore,39.2902778,-76.6125,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Maryland
1166,united states of america,bethesda,38.9805556,-77.1005556,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Bethesda Neurology - LLC
1167,united states of america,boston,42.3583333,-71.0602778,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Caritas St. Elizabeth's Hospital
1168,united states of america,milford,42.1397222,-71.5166667,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Milford Regional Medical Center
1169,united states of america,springfield,42.1013889,-72.5902778,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Springfield Neurology Associates - LLC
1170,united states of america,worcester,42.2625,-71.8027778,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Fallon Clinic at Worcester Medical Center
1171,united states of america,edina,44.8897222,-93.3497222,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Minneapolis Clinic of Neurology
1172,united states of america,kansas city,39.0997222,-94.5783333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Saint Luke's Hospital
1173,united states of america,springfield,37.2152778,-93.2980556,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,St.John's Research Institute - Inc
1174,united states of america,great falls,47.5002778,-111.3,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Benefis Physician Associates
1175,united states of america,newark,40.7355556,-74.1727778,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,UMDNJ
1176,united states of america,albany,42.6525,-73.7566667,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurological Associates of Albany - PC
1177,united states of america,latham,42.7469444,-73.7594444,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Empire Neurology - PC
1178,united states of america,patchogue,40.7655556,-73.0155556,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,South Shore Neurologic Associates
1179,united states of america,plainview,40.7763889,-73.4677778,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Island Neurological Associates
1180,united states of america,rochester,44.0216667,-92.4697222,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Rochester Medical Center
1181,united states of america,charlotte,35.2269444,-80.8433333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,The Neurological Institute - PA
1182,united states of america,dayton,39.7588889,-84.1916667,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Neurology Specialists - Inc.
1183,united states of america,corvallis,44.5647222,-123.2608333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,The Corvallis Clinic - P.C.
1184,united states of america,portland,45.5236111,-122.675,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Providence Multiple Sclerosis Center
1185,united states of america,greensburg,40.3013889,-79.5391667,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Westmoreland Neurology
1186,united states of america,philadelphia,39.9522222,-75.1641667,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Pennsylvania Health System
1187,united states of america,pittsburgh,40.4405556,-79.9961111,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Research Protocol Management Solutions
1188,united states of america,dallas,32.7833333,-96.8,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Baylor Research Institute
1189,united states of america,dallas,32.7833333,-96.8,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,University of Texas Southwestern
1190,united states of america,round rock,30.5080556,-97.6786111,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Central Texas Neurology Consultants - P.A.
1191,united states of america,san antonio,29.4238889,-98.4933333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Innovative Clinical Trials - Bexar Diagnostic Medicine Assoc.
1192,united states of america,sherman,33.6355556,-96.6086111,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Texoma Neurology Associates
1193,united states of america,seattle,47.6063889,-122.3308333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Swedish Neuroscience Institute
1194,united states of america,seattle,47.6063889,-122.3308333,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Pacific Medical Centers
1195,united states of america,tacoma,47.2530556,-122.4430556,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,MultiCare Research Institute
1196,united states of america,guaynabo,18.3594444,-66.1113889,NCT01442194,Multiple Sclerosis,RRMS,Drug,Phase 3,3600,Caribbean Center for Clinical Research - Inc
1197,united states of america,new york,40.7141667,-74.0063889,NCT02207075,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,N/A,26,Weill Cornell Medical College
1198,united states of america,new york,40.7141667,-74.0063889,NCT01226654,Multiple Sclerosis,All,Device,N/A,160,NYU Langone Medical Center
1199,united states of america,fort collins,40.5852778,-105.0838889,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1200,united states of america,cambridge,42.375,-71.1061111,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1201,united states of america,voorhees,40.4811111,-74.4836111,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1202,united states of america,grand forks,47.9252778,-97.0325,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1203,united states of america,round rock,30.5080556,-97.6786111,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1204,united states of america,norfolk,36.8466667,-76.2855556,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1205,australia,liverpool,-33.9,150.933333,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1206,australia,woodville,-34.883333,138.55,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1207,australia,box hill,-37.816667,145.133333,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1208,austria,linz,48.3,14.3,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1209,belgium,melsbroek,50.916667,4.483333,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1210,canada,saint-laurent,45.516667,-73.666667,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1211,czech republic,ostrava,49.811852,18.255282,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1212,denmark,aarhus,56.153423,10.22553,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1213,germany,bochum,51.483333,7.216667,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1214,norway,bergen,60.391111,5.324722,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1215,switzerland,bern,46.916667,7.466667,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1216,switzerland,lausanne,46.533333,6.666667,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1217,switzerland,saint gallen,47.42539,9.377615,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1218,united kingdom,liverpool,53.416667,-3,NCT01285479,Multiple Sclerosis,All,Drug,N/A,500,Novartis Investigative Site
1219,italy,orbassano,45.016667,7.533333,NCT02611401,Multiple Sclerosis,All,Behavioral,Phase 4,88,Clinical and Biological Sciences Department
1220,canada,hamilton,43.25,-79.833333,NCT02100020,Multiple Sclerosis,All,Other,N/A,130,McMaster University - Physical Activity Centre for Excellence
1221,belgium,diepenbeek,50.9,5.4,NCT02688231,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,Phase 2,45,Hasselt University
1222,belgium,overpelt,51.216667,5.416667,NCT02688231,Multiple Sclerosis,Progressive Multiple Sclerosis,Other,Phase 2,45,Revalidatie en MS centrum
1223,france,clermont-ferrand,45.779657,3.086281,NCT02769689,Multiple Sclerosis,RRMS,Drug,Phase 4,56,CHU Clermont-Ferrand
1224,germany,berlin,52.516667,13.4,NCT02695394,Multiple Sclerosis,CIS,Other,N/A,60,Charité Unversitätsmedizin Berlin - NeuroCure Clinical Research Center NCRC  
1225,france,amiens,49.9,2.3,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU d'Amiens - Hôpital Nord
1226,france,besancon,47.248778,6.018152,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Besançon - Hôpital Jean Minjoz
1227,france,bron,45.740218,4.922415,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Lyon - Hôpital Pierre Wertheimer
1228,france,caen,49.197188,-0.326822,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Caen - Hôpital Côte de Nacre
1229,france,clermont-ferrand,45.779657,3.086281,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Clermont Ferrand - Hôpital Gabriel-Montpied
1230,france,corbeil-essonnes,48.606034,2.487571,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH Sud Francilien
1231,france,cornebarrieu,43.648951,1.324073,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,Clinique des Cèdres - Capio
1232,france,dijon,47.316667,5.016667,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Dijon
1233,france,fort-de-france,14.6,-61.0833333,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Martinique - Hôpital Pierre Zobda-Quitman
1234,france,grenoble,45.171546,5.722387,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Grenoble - Hôpital A Michallon
1235,france,lille,50.632971,3.058585,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHRU de Lille - Hôpital Roger Salengro
1236,france,limoges,45.831534,1.257805,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Limoges - Hôpital Dupuytren
1237,france,lomme,50.643579,2.987148,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,Groupe Hospitalier de l'Institut Catholique de Lille
1238,france,montpellier,43.61092,3.87723,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Montpellier - Hôpital Gui de Chauliac
1239,france,nancy,48.69211,6.187756,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Nancy - Hôpital Central
1240,france,nantes,47.216509,-1.552379,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Nantes - Hôtel-Dieu
1241,france,nice,43.713644,7.25952,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Nice - Hôpital Pasteur
1242,france,nimes,43.833778,4.359623,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Nîmes - Hôpital Universitaire Carémeau
1243,france,paris,48.866667,2.333333,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,Fondation Ophtalmologique Adolphe Rothschild
1244,france,paris,48.866667,2.333333,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,APHP - Hôpital Saint-Antoine
1245,france,pau,43.299999,-0.366667,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Pau
1246,france,perpignan,42.696172,2.897098,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Perpignan - Hôpital Saint Jean
1247,france,quimper,48,-4.1,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Cornouaille - Site Quimper - Hôpital Laennec  
1248,france,reims,49.25,4.033333,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Reims - Hôpital Maison Blanche
1249,france,rennes,48.111981,-1.674291,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Rennes - Hôpital PontChaillou
1250,france,rouen,49.433333,1.083333,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Rouen - Hôpital Charles Nicolle
1251,france,saint-germain-en-laye,48.904194,2.086688,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Poissy - Saint-Germain-en-Laye
1252,france,saint-priest-en-jarez,45.475013,4.376136,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHU de Saint Etienne - Hôpital Nord
1253,france,saumur,47.256629,-0.075025,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Saumur
1254,france,strasbourg,48.600381,7.787355,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHRU de Strasbourg - Hôpital Civil
1255,france,toulouse,43.599516,1.433188,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHRU de Toulouse - Hôpital Purpan
1256,france,tours,47.394836,0.703977,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CHRU de Tours - Hôpital Bretonneau
1257,france,versailles,48.803593,2.134236,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Versailles - Hôpital Mignot
1258,france,vichy,46.128264,3.423472,NCT01817166,Multiple Sclerosis,CIS,Drug,Phase 3,316,CH de Vichy - Jacques Larin
1259,canada,london,42.983333,-81.25,NCT02634567,Multiple Sclerosis,RRMS,Behavioral,N/A,30,London Health Sciences Centre
1260,france,pau,43.299999,-0.366667,NCT02545959,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,12,Centre hospitalier F. Mitterrand
1261,turkey,istanbul,41.018611,28.964722,NCT02373098,Multiple Sclerosis,RRMS,Drug,Phase 4,60,Novartis Investigative Site  
1262,turkey,istanbul,41.018611,28.964722,NCT02373098,Multiple Sclerosis,RRMS,Drug,Phase 4,60,Novartis Investigative Site  
1263,turkey,istanbul,41.018611,28.964722,NCT02373098,Multiple Sclerosis,RRMS,Drug,Phase 4,60,Novartis Investigative Site  
1264,united states of america,minneapolis,44.98,-93.2636111,NCT02716701,Multiple Sclerosis,All,Behavioral,N/A,40,VA Medical Center
1265,united states of america,derby,41.3205556,-73.0894444,NCT02679885,Multiple Sclerosis,RRMS,Drug,Phase 4,40,Multiple Sclerosis Treatment Center at Griffin Hospital
1266,united states of america,birmingham,33.5205556,-86.8025,NCT01018537,Multiple Sclerosis,CIS,Other,N/A,50000,University of Alabama at Birmingham
1267,france,rennes,48.111981,-1.674291,NCT02388334,Multiple Sclerosis,All,Other,N/A,730,Rennes University Hospital
1268,united states of america,urbana,40.1105556,-88.2072222,NCT02314585,Multiple Sclerosis,All,Other,N/A,100,Motor control research lab
1269,italy,milan,45.466667,9.2,NCT02587065,Multiple Sclerosis,RRMS,Drug,Phase 4,275,Novartis Investigative Site  
1270,italy,pozzilli,41.516667,14.066667,NCT02587065,Multiple Sclerosis,RRMS,Drug,Phase 4,275,Novartis Investigative Site  
1271,united states of america,cullman,34.1747222,-86.8436111,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1272,united states of america,carmichael,38.6172222,-121.3272222,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1273,united states of america,atlanta,33.7488889,-84.3880556,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1274,united states of america,northbrook,42.1275,-87.8288889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1275,united states of america,foxboro,42.0583333,-71.25,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1276,united states of america,golden valley,45.0097222,-93.3488889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1277,united states of america,golden valley,45.0097222,-93.3488889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1278,united states of america,las vegas,36.175,-115.1363889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1279,united states of america,teaneck,40.8975,-74.0163889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1280,united states of america,lake success,40.7705556,-73.7180556,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1281,united states of america,raleigh,35.7719444,-78.6388889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1282,united states of america,columbus,39.9611111,-82.9988889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1283,united states of america,uniontown,40.975,-81.4083333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1284,united states of america,round rock,30.5080556,-97.6786111,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1285,united states of america,virginia beach,36.8527778,-75.9783333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1286,argentina,buenos aires,-34.5875,-58.6725,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1287,argentina,buenos aires,-34.5875,-58.6725,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1288,argentina,rosario,-32.946818,-60.639317,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1289,austria,vienna,48.2,16.366667,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1290,belgium,brussels,50.833333,4.333333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1291,belgium,edegem,51.15,4.45,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1292,croatia,rijeka,45.3430556,14.4091667,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1293,croatia,slavonski brod,45.1602778,18.0155556,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1294,croatia,split,43.5138889,16.4558333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1295,croatia,zagreb,45.8,16,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1296,croatia,zagreb,45.8,16,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1297,croatia,zagreb,45.8,16,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1298,croatia,zagreb,45.8,16,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1299,finland,tampere,61.5,23.75,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1300,finland,turku,60.45,22.283333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1301,france,besancon,47.248778,6.018152,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1302,france,bordeaux,44.840439,-0.5805,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1303,france,bron,45.740218,4.922415,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1304,france,clermont-ferrand,45.779657,3.086281,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1305,france,lille,50.632971,3.058585,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1306,france,lomme,50.643579,2.987148,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1307,france,nancy,48.69211,6.187756,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1308,france,nice,43.713644,7.25952,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1309,france,nimes,43.833778,4.359623,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1310,france,nimes,43.833778,4.359623,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1311,france,poissy,48.92902,2.049521,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1312,france,rennes,48.111981,-1.674291,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1313,france,strasbourg,48.600381,7.787355,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1314,france,toulouse,43.599516,1.433188,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1315,germany,bayreuth,49.948056,11.578333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1316,germany,dresden,51.05,13.75,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1317,germany,dresden,51.05,13.75,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1318,germany,hamburg,53.55,10,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1319,germany,rostock,54.083333,12.133333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1320,germany,stuttgart,48.766667,9.183333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1321,ireland,dublin,53.3330556,-6.2488889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1322,ireland,dublin,53.3330556,-6.2488889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1323,italy,ancona,43.633333,13.5,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1324,italy,bari,41.133333,16.85,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1325,italy,cagliari,39.216667,9.116667,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1326,italy,genova,44.416667,8.95,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1327,italy,milan,45.466667,9.2,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1328,italy,milan,45.466667,9.2,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1329,italy,montichiari,45.416667,10.383333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1330,italy,naples,40.833333,14.25,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1331,italy,rome,41.9,12.483333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1332,italy,rome,41.9,12.483333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1333,italy,rome,41.9,12.483333,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1334,mexico,mexico,19.434167,-99.138611,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1335,mexico,mexico,19.434167,-99.138611,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1336,mexico,distrito federal,32.491389,-115.036944,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1337,mexico,distrito federal,32.491389,-115.036944,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1338,mexico,mexico,19.434167,-99.138611,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1339,poland,bydgoszcz,53.127062,18.019987,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1340,poland,gdansk,54.36085,18.658291,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1341,poland,katowice,50.258415,19.027545,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1342,poland,kielce,50.833333,20.666667,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1343,poland,konskie,51.191432,20.408217,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1344,poland,lodz,51.75,19.466667,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1345,poland,lodz,51.75,19.466667,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1346,poland,lublin,51.25,22.566667,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1347,poland,olsztyn,53.779949,20.494162,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1348,poland,rybnik,50.092076,18.547479,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1349,poland,rzeszow,50.037246,22.004949,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1350,poland,warsaw,52.25,21,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1351,united states of america,guaynabo,18.3594444,-66.1113889,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1352,russia,kaluga,54.529302,36.275415,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1353,russia,kazan,55.78874,49.122144,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1354,russia,krasnoyarsk,56.0091,92.8628,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1355,russia,moscow,55.752222,37.615556,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1356,russia,moscow,55.752222,37.615556,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1357,russia,moscow,55.752222,37.615556,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1358,russia,novosibirsk,55.0415,82.9346,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1359,russia,perm,58.009282,56.284063,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1360,russia,saint petersburg,59.894444,30.264167,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1361,russia,saint petersburg,59.894444,30.264167,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1362,russia,tyumen,57.152222,65.527222,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1363,russia,volgograd,48.71939,44.501835,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1364,russia,yaroslavl,57.61977,39.85536,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1365,spain,burgos,42.350221,-3.675273,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1366,spain,madrid,40.408566,-3.69222,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1367,spain,murcia,37.987041,-1.130042,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1368,spain,malaga,36.726666,-4.434802,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1369,spain,sevilla,37.382408,-5.976133,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1370,spain,valencia,39.466667,-0.366667,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1371,turkey,ankara,39.911652,32.840305,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1372,turkey,istanbul,41.018611,28.964722,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1373,turkey,istanbul,41.018611,28.964722,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1374,turkey,izmit,40.766944,29.916944,NCT02499900,Multiple Sclerosis,RRMS,Drug,Phase 4,840,Teva Investigational Site
1375,canada,gatineau,45.483333,-75.65,NCT02623946,Multiple Sclerosis,All,Drug,N/A,10,Clinique Neuro-Outaouais
1376,israel,haifa,32.815556,34.989167,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Carmel Medical Center
1377,israel,ashkelon,31.669256,34.57149,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Barzilai Medical Center
1378,israel,jerusalem,31.78,35.23,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Hadassah Ein-Kerem
1379,israel,tel aviv,32.066667,34.766667,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,TASMC
1380,israel,tel hashomer,32.053889,34.848056,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Sheba MC
1381,israel,ness ziona,31.926389,34.803333,NCT02212886,Multiple Sclerosis,RRMS,Drug,Phase 1-Phase 2,20,Assaf Harofeh MC
1382,united states of america,phoenix,33.4483333,-112.0733333,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1383,united states of america,sarasota,27.3361111,-82.5308333,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1384,united states of america,atlanta,33.7488889,-84.3880556,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1385,united states of america,northbrook,42.1275,-87.8288889,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1386,united states of america,rochester,44.0216667,-92.4697222,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1387,united states of america,patchogue,40.7655556,-73.0155556,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1388,united states of america,raleigh,35.7719444,-78.6388889,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1389,united states of america,franklin,35.925,-86.8688889,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1390,united states of america,dallas,32.7833333,-96.8,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1391,united states of america,kirkland,47.6816667,-122.2075,NCT02471222,Multiple Sclerosis,All,Drug,Phase 2,60,Adamas Investigational Site
1392,germany,bonn,50.733333,7.1,NCT02364986,Multiple Sclerosis,RRMS,Drug,Phase 1,50,Department of Neurology
1393,germany,bonn,50.733333,7.1,NCT02364986,Multiple Sclerosis,RRMS,Drug,Phase 1,50,Phase I Unit
1394,united states of america,cullman,34.1747222,-86.8436111,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1395,united states of america,gilbert,33.3527778,-111.7883333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1396,united states of america,phoenix,33.4483333,-112.0733333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1397,united states of america,phoenix,33.4483333,-112.0733333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1398,united states of america,tucson,32.2216667,-110.9258333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1399,united states of america,carlsbad,33.1580556,-117.3497222,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1400,united states of america,fullerton,33.8702778,-117.9244444,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1401,united states of america,la jolla,32.8472222,-117.2733333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1402,united states of america,centennial,39.5791667,-104.8763889,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1403,united states of america,englewood,39.6477778,-104.9872222,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1404,united states of america,fort collins,40.5852778,-105.0838889,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1405,united states of america,fairfield,41.1411111,-73.2641667,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1406,united states of america,maitland,28.6275,-81.3633333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1407,united states of america,sunrise,26.1336111,-80.1133333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1408,united states of america,tampa,27.9472222,-82.4586111,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1409,united states of america,tampa,27.9472222,-82.4586111,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1410,united states of america,atlanta,33.7488889,-84.3880556,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1411,united states of america,chicago,41.85,-87.65,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1412,united states of america,northbrook,42.1275,-87.8288889,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1413,united states of america,avon,39.7627778,-86.3997222,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1414,united states of america,indianapolis,39.7683333,-86.1580556,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1415,united states of america,lexington,37.9886111,-84.4777778,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1416,united states of america,lexington,37.9886111,-84.4777778,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1417,united states of america,boston,42.3583333,-71.0602778,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1418,united states of america,boston,42.3583333,-71.0602778,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1419,united states of america,boston,42.3583333,-71.0602778,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1420,united states of america,edina,44.8897222,-93.3497222,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1421,united states of america,saint louis,38.6272222,-90.1977778,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1422,united states of america,freehold,40.26,-74.2741667,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1423,united states of america,newark,40.7355556,-74.1727778,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1424,united states of america,teaneck,40.8975,-74.0163889,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1425,united states of america,latham,42.7469444,-73.7594444,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1426,united states of america,mineola,40.7491667,-73.6411111,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1427,united states of america,patchogue,40.7655556,-73.0155556,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1428,united states of america,raleigh,35.7719444,-78.6388889,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1429,united states of america,akron,41.0813889,-81.5191667,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1430,united states of america,columbus,39.9611111,-82.9988889,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1431,united states of america,oklahoma city,35.4675,-97.5161111,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1432,united states of america,portland,45.5236111,-122.675,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1433,united states of america,pittsburgh,40.4405556,-79.9961111,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1434,united states of america,cordova,35.1555556,-89.7761111,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1435,united states of america,knoxville,35.9605556,-83.9208333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1436,united states of america,houston,29.7630556,-95.3630556,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1437,united states of america,lubbock,33.5777778,-101.8547222,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1438,united states of america,round rock,30.5080556,-97.6786111,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1439,united states of america,san antonio,29.4238889,-98.4933333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1440,united states of america,salt lake city,40.7608333,-111.8902778,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1441,united states of america,richmond,37.5536111,-77.4605556,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1442,united states of america,seattle,47.6063889,-122.3308333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1443,united states of america,tacoma,47.2530556,-122.4430556,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1444,canada,calgary,51.083333,-114.083333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1445,canada,edmonton,53.55,-113.5,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1446,canada,montreal,45.5,-73.583333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1447,canada,montreal,45.5,-73.583333,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1448,canada,trois-rivieres,46.35,-72.55,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1449,canada,quebec,46.8,-71.25,NCT02637856,Multiple Sclerosis,RRMS,Drug,Phase 3,600,Hoffmann-La Roche Investigational Site
1450,belgium,brussels,50.833333,4.333333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1451,belgium,gent,51.05,3.716667,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1452,belgium,la louviere,50.466667,4.183333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1453,czech republic,brno,49.2,16.633333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1454,czech republic,hradec kralove,50.207744,15.829455,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1455,czech republic,jihlava,49.4,15.583333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1456,czech republic,ostrava,49.811852,18.255282,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1457,denmark,kobenhavn,55.666667,12.583333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1458,denmark,odense,55.393475,10.394935,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1459,denmark,aarhus,56.153423,10.22553,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1460,france,strasbourg,48.600381,7.787355,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1461,france,dijon,47.316667,5.016667,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1462,france,rennes,48.111981,-1.674291,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1463,france,bron,45.740218,4.922415,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1464,france,amiens,49.9,2.3,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1465,france,lille,50.632971,3.058585,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1466,hungary,budapest,47.5,19.083333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1467,hungary,budapest,47.5,19.083333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1468,italy,gallarate,45.666667,8.783333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1469,italy,como,45.783333,9.083333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1470,italy,genova,44.416667,8.95,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1471,italy,milan,45.466667,9.2,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1472,italy,rome,41.9,12.483333,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1473,poland,bialystok,53.133333,23.15,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1474,poland,gdansk,54.36085,18.658291,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1475,poland,poznan,52.416667,16.966667,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1476,serbia,belgrade,44.818611,20.468056,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1477,serbia,belgrade,44.818611,20.468056,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1478,sweden,goteborg,57.716667,11.966667,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1479,sweden,stockholm,59.333333,18.05,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1480,united kingdom,london,51.514125,-0.093689,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1481,united kingdom,london,51.514125,-0.093689,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1482,united kingdom,birmingham,52.466667,-1.916667,NCT02283853,Multiple Sclerosis,RRMS,Drug,Phase 3,142,Biogen Investigational Site
1483,united states of america,new york,40.7141667,-74.0063889,NCT02688985,Multiple Sclerosis,RRMS,Drug,Phase 3,99,Hoffmann-La Roche Investigational Site
1484,united states of america,columbus,39.9611111,-82.9988889,NCT02688985,Multiple Sclerosis,RRMS,Drug,Phase 3,99,Hoffmann-La Roche Investigational Site
1485,united states of america,oklahoma city,35.4675,-97.5161111,NCT02688985,Multiple Sclerosis,RRMS,Drug,Phase 3,99,Hoffmann-La Roche Investigational Site
1486,united states of america,latham,42.7469444,-73.7594444,NCT02683863,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 4,20,Multiple Sclerosis Center of Northeastern New York
1487,united states of america,phoenix,33.4483333,-112.0733333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1488,united states of america,newport beach,33.6188889,-117.9280556,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1489,united states of america,san francisco,37.775,-122.4183333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1490,united states of america,aurora,39.7294444,-104.8313889,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1491,united states of america,northbrook,42.1275,-87.8288889,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1492,united states of america,kansas city,39.0997222,-94.5783333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1493,united states of america,lenexa,38.9536111,-94.7333333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1494,united states of america,golden valley,45.0097222,-93.3488889,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1495,united states of america,golden valley,45.0097222,-93.3488889,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1496,united states of america,chesterfield,38.6630556,-90.5769444,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1497,united states of america,saint louis,38.6272222,-90.1977778,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1498,united states of america,new york,40.7141667,-74.0063889,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1499,united states of america,charlotte,35.2269444,-80.8433333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1500,united states of america,columbus,39.9611111,-82.9988889,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1501,united states of america,uniontown,40.975,-81.4083333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1502,canada,halifax,44.65,-63.6,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1503,canada,montreal,45.5,-73.583333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1504,canada,calgary,51.083333,-114.083333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1505,canada,ottawa,45.416667,-75.7,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1506,canada,quebec,46.8,-71.25,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1507,canada,toronto,43.666667,-79.416667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1508,germany,bad mergentheim,49.4925,9.773611,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1509,germany,bamberg,49.866667,10.866667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1510,germany,berlin,52.516667,13.4,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1511,germany,bochum,51.483333,7.216667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1512,germany,dresden,51.05,13.75,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1513,germany,dusseldorf,51.216667,6.766667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1514,germany,gottingen,51.533333,9.933333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1515,germany,hamburg,53.55,10,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1516,germany,hanover,52.366667,9.716667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1517,germany,munich,48.15,11.5833,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1518,germany,munich,48.15,11.5833,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1519,germany,rostock,54.083333,12.133333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1520,germany,trier,49.75,6.633333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1521,germany,ulm,48.4,10,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1522,germany,wurzburg,49.787778,9.936111,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1523,italy,palermo,38.116667,13.366667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1524,italy,firenze,43.766667,11.25,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1525,italy,varese,45.8,8.833333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1526,italy,genova,44.416667,8.95,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1527,italy,milan,45.466667,9.2,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1528,italy,torino,45.05,7.666667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1529,italy,padova,45.416667,11.883333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1530,italy,rome,41.9,12.483333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1531,italy,rome,41.9,12.483333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1532,netherlands,amsterdam,52.35,4.916667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1533,netherlands,nijmegen,51.833333,5.866667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1534,netherlands,geleen,50.965741,5.834752,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1535,poland,bialystok,53.133333,23.15,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1536,poland,bydgoszcz,53.127062,18.019987,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1537,poland,gdansk,54.36085,18.658291,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1538,poland,katowice,50.258415,19.027545,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1539,poland,katowice,50.258415,19.027545,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1540,poland,katowice,50.258415,19.027545,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1541,poland,kielce,50.833333,20.666667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1542,poland,konskie,51.191432,20.408217,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1543,poland,lublin,51.25,22.566667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1544,poland,olsztyn,53.779949,20.494162,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1545,poland,warsaw,52.25,21,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1546,russia,kaluga,54.529302,36.275415,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1547,russia,kazan,55.78874,49.122144,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1548,russia,kirov,58.596654,49.660068,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1549,russia,krasnoyarsk,56.0091,92.8628,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1550,russia,moscow,55.752222,37.615556,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1551,russia,nizhniy novgorod,56.326944,44.0075,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1552,russia,novosibirsk,55.0415,82.9346,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1553,russia,perm,58.009282,56.284063,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1554,russia,saint petersburg,59.894444,30.264167,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1555,russia,saint petersburg,59.894444,30.264167,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1556,russia,saint petersburg,59.894444,30.264167,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1557,spain,barcelona,41.398371,2.1741,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1558,spain,barcelona,41.398371,2.1741,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1559,spain,el palmar,39.3,-0.316667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1560,spain,lleida,41.616667,0.633333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1561,spain,madrid,40.408566,-3.69222,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1562,spain,malaga,36.726666,-4.434802,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1563,spain,pozuelo de alarcon,40.432931,-3.813375,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1564,spain,san sebastian,28.091627,-17.113314,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1565,spain,sevilla,37.382408,-5.976133,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1566,spain,valencia,39.466667,-0.366667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1567,ukraine,dnipropetrovsk,48.46298,35.039043,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1568,ukraine,ivanofrankivsk,48.921504,24.709716,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1569,ukraine,kharkiv,49.980814,36.252718,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1570,ukraine,kiev,50.433333,30.516667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1571,ukraine,lutsk,50.759319,25.342436,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1572,ukraine,lviv,49.840661,24.030451,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1573,ukraine,lviv,49.840661,24.030451,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1574,ukraine,zaporizhzhya,47.822892,35.190314,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1575,ukraine,zaporizhzhya,47.822892,35.190314,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1576,ukraine,zaporizhzhya,47.822892,35.190314,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1577,united kingdom,bristol,51.45,-2.583333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1578,united kingdom,devonshire,50.75,-3.75,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1579,united kingdom,edinburgh,55.95,-3.2,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1580,united kingdom,liverpool,53.416667,-3,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1581,united kingdom,london,51.514125,-0.093689,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1582,united kingdom,nottingham,52.966667,-1.166667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1583,united kingdom,oxford,51.75,-1.25,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1584,united kingdom,plymouth,50.396389,-4.138611,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1585,united kingdom,stoke-on-trent,53,-2.183333,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1586,united kingdom,swansea,51.633333,-3.966667,NCT02284568,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,Phase 2,375,Teva Investigational Site
1587,united states of america,new haven,41.3080556,-72.9286111,NCT02118298,Multiple Sclerosis,All,Other,N/A,120,Yale University
1588,united states of america,saint louis,38.6272222,-90.1977778,NCT02675413,Multiple Sclerosis,RRMS,Drug,Phase 4,45,Washington University (John L. Trotter MS Center)
1589,united states of america,seattle,47.6063889,-122.3308333,NCT02675413,Multiple Sclerosis,RRMS,Drug,Phase 4,45,Swedish Neuroscience Institute
1590,germany,ostfildern,48.716667,9.266667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1591,germany,aachen,50.770833,6.105278,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1592,germany,aachen,50.770833,6.105278,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1593,germany,aalen,48.833333,10.1,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1594,germany,aalen,48.833333,10.1,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1595,germany,abensberg,48.816667,11.85,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1596,germany,achim,53.033333,9.016667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1597,germany,aichach,48.466667,11.133333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1598,germany,altenburg,50.983333,12.45,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1599,germany,altenholz,54.4,10.133333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1600,germany,alzenau,50.083333,9.066667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1601,germany,andernach,50.433333,7.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1602,germany,asbach,49.816667,7.283333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1603,germany,aschaffenburg,49.973889,9.149167,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1604,germany,augsburg,48.366667,10.883333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1605,germany,bad hersfeld,50.866667,9.7,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1606,germany,bad homburg,50.216667,8.616667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1607,germany,honnef,50.633333,7.233333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1608,germany,bad krozingen,47.916272,7.700622,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1609,germany,bad mergentheim,49.4925,9.773611,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1610,germany,bad saarow,52.283333,14.066667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1611,germany,bad wildbad,48.75,8.55,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1612,germany,bamberg,49.866667,10.866667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1613,germany,bayreuth,49.948056,11.578333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1614,germany,berg,47.966667,11.35,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1615,germany,bergisch gladbach,50.983333,7.133333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1616,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1617,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1618,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1619,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1620,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1621,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1622,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1623,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1624,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1625,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1626,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1627,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1628,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1629,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1630,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1631,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1632,germany,berlin,52.516667,13.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1633,germany,bielefeld,52.033333,8.533333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1634,germany,bielefeld,52.033333,8.533333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1635,germany,bochum,51.483333,7.216667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1636,germany,bochum,51.483333,7.216667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1637,germany,bochum,51.483333,7.216667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1638,germany,bochum,51.483333,7.216667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1639,germany,bogen,48.916667,12.683333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1640,germany,bonn,50.733333,7.1,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1641,germany,borna,51.116667,12.5,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1642,germany,braunschweig,52.266667,10.533333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1643,germany,braunschweig,52.266667,10.533333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1644,germany,bremen,53.083333,8.8,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1645,germany,bruchsal,49.128056,8.583611,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1646,germany,buchholz,53.416667,9.433333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1647,germany,buchholz,53.416667,9.433333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1648,germany,butzbach,50.433333,8.683333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1649,germany,boblingen,48.683333,9.016667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1650,germany,celle,52.616667,10.083333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1651,germany,chemnitz,50.833333,12.916667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1652,germany,delbruck,51.766667,8.566667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1653,germany,dillingen,48.566667,10.483333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1654,germany,dillingen,48.566667,10.483333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1655,germany,dortmund,51.516667,7.45,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1656,germany,dortmund,51.516667,7.45,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1657,germany,dresden,51.05,13.75,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1658,germany,dresden,51.05,13.75,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1659,germany,dusseldorf,51.216667,6.766667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1660,germany,dusseldorf,51.216667,6.766667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1661,germany,duren,50.8,6.483333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1662,germany,dusseldorf,51.216667,6.766667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1663,germany,dusseldorf,51.216667,6.766667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1664,germany,eberswalde,52.833333,13.833333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1665,germany,eisenach,50.983333,10.316667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1666,germany,eltville,50.033333,8.116667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1667,germany,emden,52.233333,11.266667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1668,germany,emmendingen,48.133333,7.85,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1669,germany,erbach,49.656111,8.996389,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1670,germany,erfurt,50.983333,11.033333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1671,germany,erfurt,50.983333,11.033333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1672,germany,erlangen,49.589722,11.003889,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1673,germany,eschwege,51.183333,10.066667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1674,germany,essen,51.45,7.016667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1675,germany,essen,51.45,7.016667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1676,germany,essen,51.45,7.016667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1677,germany,essen,51.45,7.016667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1678,germany,flensburg,54.783333,9.433333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1679,germany,frankfurt,50.116667,8.683333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1680,germany,frankfurt,50.116667,8.683333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1681,germany,frankfurt,50.116667,8.683333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1682,germany,frankfurt,50.116667,8.683333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1683,germany,freiburg,48,7.85,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1684,germany,fulda,50.55,9.666667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1685,germany,geldern,51.516667,6.333333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1686,germany,gelnhausen,50.2,9.183333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1687,germany,gelsenkirchen,51.516667,7.05,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1688,germany,gilching,48.116667,11.3,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1689,germany,gladenbach,50.766667,8.566667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1690,germany,gottingen,51.533333,9.933333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1691,germany,greifswald,54.1,13.383333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1692,germany,grevenbroich,51.083333,6.583333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1693,germany,griesheim,49.862778,8.575278,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1694,germany,gutersloh,51.9,8.383333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1695,germany,gummersbach,51.033333,7.55,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1696,germany,gottingen,51.533333,9.933333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1697,germany,haar,48.1,11.733333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1698,germany,hagen,51.35,7.466667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1699,germany,halle,51.5,12,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1700,germany,halle,51.5,12,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1701,germany,hamburg,53.55,10,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1702,germany,hamburg,53.55,10,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1703,germany,hamburg,53.55,10,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1704,germany,hamburg,53.55,10,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1705,germany,hamburg,53.55,10,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1706,germany,hamburg,53.55,10,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1707,germany,hanover,52.366667,9.716667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1708,germany,hanover,52.366667,9.716667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1709,germany,hanover,52.366667,9.716667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1710,germany,heidelberg,49.416667,8.7,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1711,germany,heidenheim,48.683333,10.15,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1712,germany,herford,52.133333,8.683333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1713,germany,herford,52.133333,8.683333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1714,germany,hildesheim,52.15,9.966667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1715,germany,homburg,49.316667,7.333333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1716,germany,hoppegarten,52.483333,14.016667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1717,germany,ibbenburen,52.266667,7.733333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1718,germany,idar-oberstein,49.7,7.3,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1719,germany,itzehoe,53.916667,9.516667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1720,germany,jena,50.933333,11.583333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1721,germany,jena,50.933333,11.583333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1722,germany,julich,50.933333,6.366667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1723,germany,kaiserslautern,49.45,7.75,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1724,germany,kaltenkirchen,53.833333,9.966667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1725,germany,kandel,49.089167,8.184167,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1726,germany,karlstadt,49.960278,9.772222,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1727,germany,kassel,51.316667,9.5,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1728,germany,kiel,54.333333,10.133333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1729,germany,klingenmunster,49.140556,8.018611,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1730,germany,koln,50.933333,6.95,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1731,germany,koln,50.933333,6.95,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1732,germany,korbach,51.283333,8.866667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1733,germany,krefeld,51.333333,6.566667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1734,germany,krefeld,51.333333,6.566667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1735,germany,koln,50.933333,6.95,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1736,germany,konigsbruck,51.266667,13.9,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1737,germany,landshut,48.533333,12.15,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1738,germany,lappersdorf,49.056944,12.09,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1739,germany,leipzig,51.3,12.333333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1740,germany,leipzig,51.3,12.333333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1741,germany,leipzig,51.3,12.333333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1742,germany,leverkusen,51.016667,6.983333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1743,germany,lohr,49.993611,9.578333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1744,germany,ludwigshafen,49.481111,8.435278,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1745,germany,ludwigshafen,49.481111,8.435278,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1746,germany,eisleben,52.15,11.216667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1747,germany,luneburg,53.25,10.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1748,germany,lunen,51.616667,7.516667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1749,germany,magdeburg,52.166667,11.666667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1750,germany,magdeburg,52.166667,11.666667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1751,germany,mannheim,49.488333,8.464722,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1752,germany,mannheim,49.488333,8.464722,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1753,germany,mannheim,49.488333,8.464722,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1754,germany,marburg,50.816667,8.766667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1755,germany,meisenheim,49.716667,7.666667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1756,germany,minden,52.283333,8.916667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1757,germany,minden,52.283333,8.916667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1758,germany,mittweida,50.983333,12.983333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1759,germany,muenster,51.966667,7.633333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1760,germany,monchengladbach,51.2,6.433333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1761,germany,mulheim,51.433333,6.883333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1762,germany,munich,48.15,11.5833,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1763,germany,munich,48.15,11.5833,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1764,germany,munich,48.15,11.5833,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1765,germany,munster,51.966667,7.633333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1766,germany,nagold,48.55,8.716667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1767,germany,naumburg,51.15,11.816667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1768,germany,ulm,48.4,10,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1769,germany,neuburg,49.346667,12.384444,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1770,germany,neuruppin,52.933333,12.8,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1771,germany,neustadt an der weinstrasse,49.356667,8.137778,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1772,germany,neusass,48.4,10.833333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1773,germany,nurnberg,49.447778,11.068333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1774,germany,offenbach,50.1,8.766667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1775,germany,oldenburg,53.166667,8.2,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1776,germany,oldenburg,53.166667,8.2,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1777,germany,osnabruck,52.266667,8.05,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1778,germany,osnabruck,52.266667,8.05,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1779,germany,osnabruck,52.266667,8.05,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1780,germany,papenburg,53.066667,7.4,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1781,germany,pforzheim,48.883333,8.7,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1782,germany,potsdam,52.4,13.066667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1783,germany,prien,47.866667,12.333333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1784,germany,quakenbruck,52.683333,7.95,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1785,germany,querfurt,51.383333,11.6,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1786,germany,ravensburg,47.783333,9.616667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1787,germany,recklinghausen,51.616667,7.2,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1788,germany,regensburg,49.015,12.095556,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1789,germany,remscheid,51.183333,7.2,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1790,germany,rostock,54.083333,12.133333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1791,germany,rudersdorf,52.45,13.783333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1792,germany,sande,53.5,8,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1793,germany,schwalmstadt,50.933333,9.216667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1794,germany,schwerin,53.633333,11.383333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1795,germany,siegen,50.866667,8.033333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1796,germany,singen,47.766667,8.833333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1797,germany,sinsheim,49.255278,8.877222,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1798,germany,sankt ingbert,49.283333,7.116667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1799,germany,stade,53.6,9.483333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1800,germany,stadtroda,50.85,11.733333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1801,germany,stralsund,54.3,13.1,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1802,germany,stuttgart,48.766667,9.183333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1803,germany,stuttgart,48.766667,9.183333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1804,germany,stuttgart,48.766667,9.183333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1805,germany,stuttgart,48.766667,9.183333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1806,germany,telgte,51.983333,7.783333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1807,germany,teupitz,52.116667,13.616667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1808,germany,troisdorf,50.816667,7.166667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1809,germany,tubingen,48.533333,9.05,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1810,germany,ulm,48.4,10,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1811,germany,ulm,48.4,10,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1812,germany,unterhaching,48.05,11.633333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1813,germany,wasserburg,48.066667,12.233333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1814,germany,wendlingen,48.683333,9.383333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1815,germany,wermsdorf,51.283333,12.95,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1816,germany,westerstede,53.25,7.933333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1817,germany,wiesbaden,50.083333,8.25,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1818,germany,wiesbaden,50.083333,8.25,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1819,germany,wolfratshausen,47.916667,11.416667,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1820,germany,wuppertal,51.266667,7.183333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1821,germany,wuppertal,51.266667,7.183333,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1822,germany,wurzburg,49.787778,9.936111,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1823,germany,wurzburg,49.787778,9.936111,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1824,germany,zwickau,50.733333,12.5,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1825,germany,ohringen,49.201667,9.503889,NCT01585298,Multiple Sclerosis,RRMS,Drug,Phase 4,7000,Novartis Investigative Site
1826,united states of america,seattle,47.6063889,-122.3308333,NCT02474940,Multiple Sclerosis,All,Behavioral,N/A,30,University of Washington - Ninth and Jefferson Building
1827,united states of america,tucson,32.2216667,-110.9258333,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1828,united states of america,fullerton,33.8702778,-117.9244444,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1829,united states of america,la jolla,32.8472222,-117.2733333,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1830,united states of america,maitland,28.6275,-81.3633333,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1831,united states of america,miami,25.7738889,-80.1938889,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1832,united states of america,tampa,27.9472222,-82.4586111,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1833,united states of america,farmington hills,42.4852778,-83.3772222,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1834,united states of america,golden valley,45.0097222,-93.3488889,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1835,united states of america,chesterfield,38.6630556,-90.5769444,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1836,united states of america,albuquerque,35.0844444,-106.6505556,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1837,united states of america,new york,40.7141667,-74.0063889,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1838,united states of america,charlotte,35.2269444,-80.8433333,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1839,united states of america,columbus,39.9611111,-82.9988889,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1840,united states of america,dayton,39.7588889,-84.1916667,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1841,united states of america,willow grove,40.1438889,-75.1161111,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1842,united states of america,cordova,35.1555556,-89.7761111,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1843,united states of america,round rock,30.5080556,-97.6786111,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1844,united states of america,salt lake city,40.7608333,-111.8902778,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1845,united states of america,seattle,47.6063889,-122.3308333,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1846,united states of america,milwaukee,43.0388889,-87.9063889,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1847,canada,calgary,51.083333,-114.083333,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1848,canada,vancouver,49.25,-123.133333,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1849,canada,montreal,45.5,-73.583333,NCT02545868,Multiple Sclerosis,RRMS,Biological,Phase 3,100,Hoffmann-La Roche Investigative Site
1850,united states of america,kirkland,47.6816667,-122.2075,NCT02490943,Multiple Sclerosis,RRMS,Other,Phase 1,28,Evergreen Health
1851,united states of america,portland,45.5236111,-122.675,NCT02340754,Multiple Sclerosis,All,Behavioral,N/A,60,National College of Natural Medicine
1852,united kingdom,glasgow,55.833333,-4.25,NCT02559765,Multiple Sclerosis,Progressive Multiple Sclerosis,Behavioral,N/A,1500,The University of Glasgow
1853,canada,montreal,45.5,-73.583333,NCT02408380,Multiple Sclerosis,All,Drug,N/A,216,McGill University
1854,united states of america,new haven,41.3080556,-72.9286111,NCT02218879,Multiple Sclerosis,RRMS,Drug,N/A,20,Yale University
1855,ireland,limerick,52.6647222,-8.6230556,NCT02301442,Multiple Sclerosis,All,Behavioral,N/A,72,Department of Clinical Therapies - University of Limerick
1856,france,paris,48.866667,2.333333,NCT02305264,Multiple Sclerosis,Progressive Multiple Sclerosis,Drug,N/A,65,Pitie Salpetriere Hospital
1857,finland,turku,60.45,22.283333,NCT02139696,Multiple Sclerosis,All,Other,N/A,10,Turku University Hospital
1858,switzerland,basel,47.558395,7.573271,NCT02142946,Multiple Sclerosis,All,Other,N/A,300,Lab for Exp Otoneurology - University Hospital Basel  
1859,united states of america,birmingham,33.5205556,-86.8025,NCT02533882,Multiple Sclerosis,All,Behavioral,N/A,240,Lakeshore Foundation
1860,trinidad and tobago,san fernando,10.2833333,-61.4666667,NCT02587715,Multiple Sclerosis,All,Stem Cells,Phase 1-Phase 2,69,Novo Cellular Medicine Institute
1861,switzerland,valens,46.966581,9.477047,NCT02571335,Multiple Sclerosis,All,Behavioral,N/A,80,Kliniken-Valens
1862,united states of america,new york,40.7141667,-74.0063889,NCT02446886,Multiple Sclerosis,All,Drug,Phase 4,30,Weill Cornell Medical College
1863,united states of america,aurora,39.7294444,-104.8313889,NCT02307877,Multiple Sclerosis,All,Drug,Phase 4,120,University of Colorado Hospital
1864,canada,hamilton,43.25,-79.833333,NCT01738347,Multiple Sclerosis,RRMS,Drug,Phase 1,30,St. Joseph Healthcare
1865,united states of america,oakland,37.8044444,-122.2697222,NCT02743312,Multiple Sclerosis,All,Device,N/A,5,Samuel Merritt University - Motion Analysis Research Center
1866,czech republic,brno,49.2,16.633333,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1867,czech republic,brno,49.2,16.633333,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1868,czech republic,ceske budejovice,48.983333,14.466667,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1869,czech republic,hradec kralove,50.207744,15.829455,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1870,czech republic,jihlava,49.4,15.583333,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1871,czech republic,olomouc,49.59404,17.25119,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1872,czech republic,ostrava,49.811852,18.255282,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1873,czech republic,pardubice,50.027778,15.775833,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1874,czech republic,plzen,49.75,13.366667,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1875,czech republic,prague,50.083333,14.466667,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1876,czech republic,prague,50.083333,14.466667,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1877,czech republic,prague,50.083333,14.466667,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1878,czech republic,prague,50.083333,14.466667,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1879,czech republic,teplice,50.646569,13.840138,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1880,czech republic,zlin,49.216667,17.666667,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1881,mexico,zapopan,20.716667,-103.4,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1882,mexico,monterrey,25.666667,-100.316667,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1883,mexico,monterrey,25.666667,-100.316667,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1884,mexico,aguascalientes,21.883333,-102.3,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1885,mexico,estado de mexico,18,-90.890278,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1886,mexico,mexico,19.434167,-99.138611,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1887,mexico,mexico,19.434167,-99.138611,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1888,mexico,mexico,19.434167,-99.138611,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1889,mexico,mexico,19.434167,-99.138611,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1890,mexico,mexico,19.434167,-99.138611,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1891,mexico,puebla,19.05,-98.2,NCT00493298,Multiple Sclerosis,RRMS,Drug,Phase 2,6000,Biogen Investigative Site
1892,united states of america,new york,40.7141667,-74.0063889,NCT02665221,Multiple Sclerosis,RRMS,Other,Phase 1,40,New York University School of Medicine
1893,united states of america,san francisco,37.775,-122.4183333,NCT02710214,Multiple Sclerosis,All,Drug,Phase 2,24,University of California - San Francisco
1894,united states of america,bethesda,38.9805556,-77.1005556,NCT00794352,Multiple Sclerosis,All,Other,N/A,1200,National Institutes of Health Clinical Center - 9000 Rockville Pike
1895,germany,muenster,51.966667,7.633333,NCT02325440,Multiple Sclerosis,RRMS,Drug,Phase 4,15,Universitaetsklinikum Muenster - Department of Neurology
1896,argentina,buenos aires,-34.5875,-58.6725,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1897,argentina,buenos aires,-34.5875,-58.6725,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1898,argentina,buenos aires,-34.5875,-58.6725,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1899,argentina,santiago del estero,-27.795112,-64.261489,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1900,canada,brampton,43.683333,-79.766667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1901,canada,burnaby,49.25,-122.95,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1902,canada,fredericton,45.95,-66.633333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1903,canada,london,42.983333,-81.25,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1904,czech republic,hradec kralove,50.207744,15.829455,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1905,czech republic,jihlava,49.4,15.583333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1906,czech republic,olomouc,49.59404,17.25119,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1907,czech republic,ostrava,49.811852,18.255282,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1908,czech republic,prague,50.083333,14.466667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1909,czech republic,teplice,50.646569,13.840138,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1910,france,agen,44.199912,0.626641,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1911,france,angers,47.473806,-0.54774,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1912,france,bayonne,43.483333,-1.483333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1913,france,bois-guillaume,49.460197,1.12219,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1914,france,bordeaux,44.840439,-0.5805,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1915,france,caen,49.197188,-0.326822,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1916,france,cahors,44.454598,1.43924,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1917,france,cergy,49.036448,2.076133,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1918,france,colmar,48.078708,7.355401,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1919,france,dijon,47.316667,5.016667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1920,france,gonesse,48.986928,2.448922,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1921,france,la seyne-sur-mer,43.098184,5.884715,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1922,france,le mans,48.000386,0.204709,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1923,france,lille,50.632971,3.058585,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1924,france,limoges,45.831534,1.257805,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1925,france,lisieux,49.147664,0.226625,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1926,france,mantes-la-jolie,48.990163,1.70792,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1927,france,marseille,43.285413,5.37606,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1928,france,annecy,45.906206,6.126699,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1929,france,montauban,44.018194,1.364319,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1930,france,montbeliard,47.510316,6.798629,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1931,france,montpellier,43.61092,3.87723,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1932,france,montpellier,43.61092,3.87723,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1933,france,nancy,48.69211,6.187756,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1934,france,nimes,43.833778,4.359623,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1935,france,niort,46.323875,-0.461334,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1936,france,nogent-sur-marne,48.838814,2.478642,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1937,france,paris,48.866667,2.333333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1938,france,paris,48.866667,2.333333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1939,france,poitiers,46.583333,0.333333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1940,france,rambouillet,48.642276,1.831259,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1941,france,reims,49.25,4.033333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1942,france,rennes,48.111981,-1.674291,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1943,france,roanne,46.043291,4.068553,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1944,france,rouen,49.433333,1.083333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1945,france,saint-denis,48.934172,2.354805,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1946,france,saint malo,47.312574,3.267809,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1947,france,toulouse,43.599516,1.433188,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1948,france,tourcoing,50.723907,3.161168,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1949,germany,abensberg,48.816667,11.85,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1950,germany,altenholz,54.4,10.133333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1951,germany,aschaffenburg,49.973889,9.149167,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1952,germany,bad krozingen,47.916272,7.700622,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1953,germany,bamberg,49.866667,10.866667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1954,germany,bayreuth,49.948056,11.578333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1955,germany,berlin,52.516667,13.4,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1956,germany,bielefeld,52.033333,8.533333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1957,germany,bochum,51.483333,7.216667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1958,germany,boblingen,48.683333,9.016667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1959,germany,bogen,48.916667,12.683333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1960,germany,bonn,50.733333,7.1,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1961,germany,butzbach,50.433333,8.683333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1962,germany,dresden,51.05,13.75,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1963,germany,eisenach,50.983333,10.316667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1964,germany,erbach,49.656111,8.996389,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1965,germany,essen,51.45,7.016667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1966,germany,frankfurt,50.116667,8.683333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1967,germany,freiburg,48,7.85,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1968,germany,gottingen,51.533333,9.933333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1969,germany,grevenbroich,51.083333,6.583333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1970,germany,halle,51.5,12,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1971,germany,hamburg,53.55,10,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1972,germany,hemmoor,53.7,9.116667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1973,germany,homburg,49.316667,7.333333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1974,germany,itzehoe,53.916667,9.516667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1975,germany,jena,50.933333,11.583333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1976,germany,kaltenkirchen,53.833333,9.966667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1977,germany,karlstadt,49.960278,9.772222,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1978,germany,kirchberg,50.616667,12.533333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1979,germany,landshut,48.533333,12.15,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1980,germany,lappersdorf,49.056944,12.09,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1981,germany,leipzig,51.3,12.333333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1982,germany,lengerich,52.183333,7.866667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1983,germany,lohr,49.993611,9.578333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1984,germany,mannheim,49.488333,8.464722,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1985,germany,muehlhausen,49.166667,11.45,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1986,germany,ulm,48.4,10,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1987,germany,neuburg,49.346667,12.384444,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1988,germany,neusass,48.4,10.833333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1989,germany,oldenburg,53.166667,8.2,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1990,germany,osnabruck,52.266667,8.05,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1991,germany,ostfildern,48.716667,9.266667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1992,germany,potsdam,52.4,13.066667,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1993,germany,quakenbruck,52.683333,7.95,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1994,germany,rosrath,50.9,7.2,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1995,germany,singen,47.766667,8.833333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1996,germany,sinsheim,49.255278,8.877222,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1997,germany,stade,53.6,9.483333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1998,germany,stadtroda,50.85,11.733333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
1999,germany,stuttgart,48.766667,9.183333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2000,germany,trier,49.75,6.633333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2001,germany,ulm,48.4,10,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2002,germany,unterhaching,48.05,11.633333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2003,germany,wermsdorf,51.283333,12.95,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2004,ireland,dublin,53.3330556,-6.2488889,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2005,israel,ness ziona,31.926389,34.803333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2006,israel,holon,32.011389,34.772222,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2007,norway,bergen,60.391111,5.324722,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2008,norway,molde,62.733333,7.183333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2009,portugal,amadora,38.759711,-9.239708,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2010,portugal,braga,41.550323,-8.420052,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2011,portugal,lisboa,38.716667,-9.133333,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2012,portugal,porto,41.149606,-8.610993,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2013,portugal,viana do castelo,41.693234,-8.832869,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2014,spain,sant cugat del valles,41.471379,2.081834,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2015,spain,terrassa,41.561111,2.008056,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2016,spain,pamplona,42.814075,-1.641153,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2017,spain,avila,40.657237,-4.699511,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2018,spain,caceres,39.481877,-6.373222,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2019,spain,girona,41.984444,2.821111,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2020,spain,la coruna,43.366609,-8.406812,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2021,spain,madrid,40.408566,-3.69222,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2022,spain,malaga,36.726666,-4.434802,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2023,spain,palma de mallorca,39.574337,2.655222,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2024,spain,segovia,40.948083,-4.11839,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2025,spain,valladolid,41.655181,-4.72372,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2026,spain,zaragoza,41.64531,-0.884861,NCT01480063,Multiple Sclerosis,All,Drug,Phase 1,5000,Biogen Investigative Site
2027,united states of america,homewood,33.4716667,-86.8008333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2028,united states of america,gilbert,33.3527778,-111.7883333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2029,united states of america,tucson,32.2216667,-110.9258333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2030,united states of america,tucson,32.2216667,-110.9258333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2031,united states of america,berkeley,37.8716667,-122.2716667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2032,united states of america,california city,35.1258333,-117.985,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2033,united states of america,panorama city,34.2247222,-118.4488889,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2034,united states of america,centennial,39.5791667,-104.8763889,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2035,united states of america,englewood,39.6477778,-104.9872222,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2036,united states of america,dover,39.1580556,-75.5247222,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2037,united states of america,washington,38.895,-77.0366667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2038,united states of america,washington,38.895,-77.0366667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2039,united states of america,delray beach,26.4611111,-80.0730556,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2040,united states of america,sarasota,27.3361111,-82.5308333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2041,united states of america,saint petersburg,27.7705556,-82.6794444,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2042,united states of america,tampa,27.9472222,-82.4586111,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2043,united states of america,atlanta,33.7488889,-84.3880556,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2044,united states of america,flossmoor,41.5427778,-87.6847222,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2045,united states of america,peoria,40.6936111,-89.5888889,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2046,united states of america,indianapolis,39.7683333,-86.1580556,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2047,united states of america,iowa city,41.6611111,-91.53,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2048,united states of america,louisville,38.2541667,-85.7594444,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2049,united states of america,scarborough,43.5780556,-70.3222222,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2050,united states of america,boston,42.3583333,-71.0602778,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2051,united states of america,boston,42.3583333,-71.0602778,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2052,united states of america,foxboro,42.0583333,-71.25,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2053,united states of america,lexington,42.4472222,-71.225,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2054,united states of america,worcester,42.2625,-71.8027778,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2055,united states of america,farmington,42.4644444,-83.3763889,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2056,united states of america,golden valley,45.0097222,-93.3488889,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2057,united states of america,saint louis,38.6272222,-90.1977778,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2058,united states of america,saint louis,38.6272222,-90.1977778,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2059,united states of america,great falls,47.5002778,-111.3,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2060,united states of america,lincoln,40.8,-96.6666667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2061,united states of america,lebanon,43.6422222,-72.2522222,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2062,united states of america,freehold,40.26,-74.2741667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2063,united states of america,buffalo,42.8863889,-78.8786111,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2064,united states of america,new hyde park,40.735,-73.6883333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2065,united states of america,new york,40.7141667,-74.0063889,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2066,united states of america,charlotte,35.2269444,-80.8433333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2067,united states of america,raleigh,35.7719444,-78.6388889,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2068,united states of america,canton,40.7988889,-81.3786111,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2069,united states of america,dayton,39.7588889,-84.1916667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2070,united states of america,dayton,39.7588889,-84.1916667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2071,united states of america,oklahoma city,35.4675,-97.5161111,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2072,united states of america,medford,42.3266667,-122.8744444,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2073,united states of america,portland,45.5236111,-122.675,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2074,united states of america,pittsburgh,40.4405556,-79.9961111,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2075,united states of america,port royal,32.3788889,-80.6927778,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2076,united states of america,spartanburg,34.9494444,-81.9322222,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2077,united states of america,knoxville,35.9605556,-83.9208333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2078,united states of america,houston,29.7630556,-95.3630556,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2079,united states of america,salt lake city,40.7608333,-111.8902778,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2080,united states of america,richmond,37.5536111,-77.4605556,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2081,united states of america,virginia beach,36.8527778,-75.9783333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2082,united states of america,tacoma,47.2530556,-122.4430556,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2083,united states of america,milwaukee,43.0388889,-87.9063889,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2084,united states of america,neenah,44.1858333,-88.4625,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2085,australia,heidelberg,-37.75,145.066667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2086,denmark,esbjerg,55.470276,8.451869,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2087,denmark,sonderborg,54.910634,9.792843,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2088,germany,aalen,48.833333,10.1,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2089,germany,freiburg,48,7.85,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2090,germany,heidenheim,48.683333,10.15,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2091,germany,ladenburg,49.475,8.606944,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2092,germany,mannheim,49.488333,8.464722,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2093,germany,pforzheim,48.883333,8.7,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2094,germany,stuttgart,48.766667,9.183333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2095,germany,bamberg,49.866667,10.866667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2096,germany,immenstadt im allgau,47.566667,10.216667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2097,germany,munich,48.15,11.5833,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2098,germany,regensburg,49.015,12.095556,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2099,germany,regensburg,49.015,12.095556,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2100,germany,rudersdorf,52.45,13.783333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2101,germany,bad homburg,50.216667,8.616667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2102,germany,butzbach,50.433333,8.683333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2103,germany,frankfurt,50.116667,8.683333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2104,germany,gelnhausen,50.2,9.183333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2105,germany,kassel,51.316667,9.5,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2106,germany,emden,52.233333,11.266667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2107,germany,gottingen,51.533333,9.933333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2108,germany,oldenburg,53.166667,8.2,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2109,germany,sande,53.5,8,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2110,germany,stade,53.6,9.483333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2111,germany,aachen,50.770833,6.105278,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2112,germany,dusseldorf,51.216667,6.766667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2113,germany,essen,51.45,7.016667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2114,germany,koln,50.933333,6.95,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2115,germany,remscheid,51.183333,7.2,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2116,germany,siegen,50.866667,8.033333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2117,germany,kandel,49.089167,8.184167,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2118,germany,katzenelnbogen,50.283333,7.95,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2119,germany,ludwigshafen,49.481111,8.435278,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2120,germany,chemnitz,50.833333,12.916667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2121,germany,leipzig,51.3,12.333333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2122,germany,leipzig,51.3,12.333333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2123,germany,itzehoe,53.916667,9.516667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2124,germany,kiel,54.333333,10.133333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2125,germany,altenburg,50.983333,12.45,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2126,germany,erfurt,50.983333,11.033333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2127,germany,jena,50.933333,11.583333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2128,germany,stadtroda,50.85,11.733333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2129,germany,berlin,52.516667,13.4,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2130,germany,berlin,52.516667,13.4,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2131,germany,berlin,52.516667,13.4,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2132,germany,berlin,52.516667,13.4,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2133,germany,berlin,52.516667,13.4,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2134,germany,hamburg,53.55,10,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2135,germany,hamburg,53.55,10,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2136,ireland,dublin,53.3330556,-6.2488889,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2137,united kingdom,irvine,55.6,-4.666667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2138,united kingdom,inverness,57.466667,-4.233333,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2139,united kingdom,glasgow,55.833333,-4.25,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2140,united kingdom,swansea,51.633333,-3.966667,NCT02230969,Multiple Sclerosis,RRMS,Drug,Phase 3,1600,Biogen Investigative Site
2141,united states of america,houston,29.7630556,-95.3630556,NCT02466074,Multiple Sclerosis,All,Drug,Phase 1-Phase 2,20,UTHealth
2142,france,besancon,47.248778,6.018152,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Besançon
2143,france,bordeaux,44.840439,-0.5805,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Bordeaux
2144,france,caen,49.197188,-0.326822,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Caen
2145,france,lille,50.632971,3.058585,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,Chu Lille
2146,france,marseille,43.285413,5.37606,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,Chu La Timone
2147,france,nancy,48.69211,6.187756,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Nancy
2148,france,nantes,47.216509,-1.552379,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Nantes
2149,france,nice,43.713644,7.25952,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Nice
2150,france,nimes,43.833778,4.359623,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHU Nîmes
2151,france,strasbourg,48.600381,7.787355,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,CHRU Strasbourg
2152,germany,munster,51.966667,7.633333,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,Université de Muenter
2153,spain,barcelona,41.398371,2.1741,NCT01981161,Multiple Sclerosis,RRMS,Other,Phase 4,600,Hôpital Vall D'Hebron
2154,norway,drammen,59.7425,10.211667,NCT01720849,Multiple Sclerosis,All,Drug,Phase 2,50,Vestre Viken Helseforetak
2155,united states of america,salt lake city,40.7608333,-111.8902778,NCT02440126,Multiple Sclerosis,All,Drug,N/A,200,Rocky Mountain MS Research Group
2156,united states of america,columbus,39.9611111,-82.9988889,NCT02717429,Multiple Sclerosis,All,Behavioral,N/A,60,Department of Psychology - The Ohio State University
2157,united states of america,los angeles,34.0522222,-118.2427778,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,Cedars-Sinai Medical Center
2158,united states of america,kansas city,39.0997222,-94.5783333,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,University of Missouri - Kansas City
2159,united states of america,state college,40.7933333,-77.8602778,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,Penn State University
2160,germany,berlin,52.516667,13.4,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,Charité University
2161,germany,hamburg,53.55,10,NCT02740361,Multiple Sclerosis,All,Behavioral,N/A,400,Universitätsklinikum Hamburg-Eppendorf
2162,switzerland,basel,47.558395,7.573271,NCT02277964,Multiple Sclerosis,RRMS,Drug,Phase 4,40,University Hospital Basel - Switzerland
2163,united states of america,homewood,33.4716667,-86.8008333,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2164,united states of america,newport beach,33.6188889,-117.9280556,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2165,united states of america,atlanta,33.7488889,-84.3880556,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2166,united states of america,buffalo,42.8863889,-78.8786111,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2167,united states of america,patchogue,40.7655556,-73.0155556,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2168,united states of america,huntersville,35.4105556,-80.8430556,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2169,united states of america,seattle,47.6063889,-122.3308333,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2170,united states of america,milwaukee,43.0388889,-87.9063889,NCT02519413,Multiple Sclerosis,RRMS,Drug,Phase 4,1500,Biogen Investigative Site
2171,united states of america,cullman,34.1747222,-86.8436111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2172,united states of america,phoenix,33.4483333,-112.0733333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2173,united states of america,phoenix,33.4483333,-112.0733333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2174,united states of america,phoenix,33.4483333,-112.0733333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2175,united states of america,los angeles,34.0522222,-118.2427778,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2176,united states of america,sacramento,38.5816667,-121.4933333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2177,united states of america,torrance,33.8358333,-118.3397222,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2178,united states of america,aurora,39.7294444,-104.8313889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2179,united states of america,denver,39.7391667,-104.9841667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2180,united states of america,loveland,40.3977778,-105.0744444,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2181,united states of america,fairfield,41.1411111,-73.2641667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2182,united states of america,newark,39.6836111,-75.75,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2183,united states of america,washington,38.895,-77.0366667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2184,united states of america,jacksonville,30.3319444,-81.6558333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2185,united states of america,maitland,28.6275,-81.3633333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2186,united states of america,ormond beach,29.2855556,-81.0561111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2187,united states of america,pompano beach,26.2375,-80.125,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2188,united states of america,port charlotte,26.9758333,-82.0908333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2189,united states of america,sarasota,27.3361111,-82.5308333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2190,united states of america,sarasota,27.3361111,-82.5308333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2191,united states of america,tallahassee,30.4380556,-84.2808333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2192,united states of america,tampa,27.9472222,-82.4586111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2193,united states of america,vero beach,27.6383333,-80.3975,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2194,united states of america,west palm beach,26.715,-80.0536111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2195,united states of america,atlanta,33.7488889,-84.3880556,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2196,united states of america,elk grove village,42.0038889,-87.9702778,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2197,united states of america,evanston,42.0411111,-87.69,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2198,united states of america,flossmoor,41.5427778,-87.6847222,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2199,united states of america,northbrook,42.1275,-87.8288889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2200,united states of america,indianapolis,39.7683333,-86.1580556,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2201,united states of america,west des moines,41.5772222,-93.7111111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2202,united states of america,kansas city,39.0997222,-94.5783333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2203,united states of america,lenexa,38.9536111,-94.7333333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2204,united states of america,louisville,38.2541667,-85.7594444,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2205,united states of america,new orleans,29.9544444,-90.075,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2206,united states of america,boston,42.3583333,-71.0602778,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2207,united states of america,springfield,42.1013889,-72.5902778,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2208,united states of america,detroit,42.3313889,-83.0458333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2209,united states of america,grand rapids,42.9633333,-85.6680556,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2210,united states of america,kansas city,39.0997222,-94.5783333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2211,united states of america,saint louis,38.6272222,-90.1977778,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2212,united states of america,saint louis,38.6272222,-90.1977778,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2213,united states of america,great falls,47.5002778,-111.3,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2214,united states of america,las vegas,36.175,-115.1363889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2215,united states of america,freehold,40.26,-74.2741667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2216,united states of america,newark,40.7355556,-74.1727778,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2217,united states of america,teaneck,40.8975,-74.0163889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2218,united states of america,albuquerque,35.0844444,-106.6505556,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2219,united states of america,albuquerque,35.0844444,-106.6505556,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2220,united states of america,amherst,42.9783333,-78.8,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2221,united states of america,buffalo,42.8863889,-78.8786111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2222,united states of america,patchogue,40.7655556,-73.0155556,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2223,united states of america,rochester,44.0216667,-92.4697222,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2224,united states of america,stony brook,40.9255556,-73.1413889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2225,united states of america,syracuse,43.0480556,-76.1477778,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2226,united states of america,chapel hill,35.9130556,-79.0561111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2227,united states of america,charlotte,35.2269444,-80.8433333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2228,united states of america,winston-salem,36.0997222,-80.2444444,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2229,united states of america,akron,41.0813889,-81.5191667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2230,united states of america,bellevue,41.2736111,-82.8416667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2231,united states of america,columbus,39.9611111,-82.9988889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2232,united states of america,columbus,39.9611111,-82.9988889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2233,united states of america,dayton,39.7588889,-84.1916667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2234,united states of america,toledo,41.6638889,-83.5552778,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2235,united states of america,oklahoma city,35.4675,-97.5161111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2236,united states of america,portland,45.5236111,-122.675,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2237,united states of america,philadelphia,39.9522222,-75.1641667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2238,united states of america,spartanburg,34.9494444,-81.9322222,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2239,united states of america,knoxville,35.9605556,-83.9208333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2240,united states of america,memphis,35.1494444,-90.0488889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2241,united states of america,nashville,36.1658333,-86.7844444,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2242,united states of america,dallas,32.7833333,-96.8,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2243,united states of america,houston,29.7630556,-95.3630556,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2244,united states of america,round rock,30.5080556,-97.6786111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2245,united states of america,san antonio,29.4238889,-98.4933333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2246,united states of america,sherman,33.6355556,-96.6086111,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2247,united states of america,alexandria,38.8047222,-77.0472222,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2248,united states of america,charlottesville,38.0291667,-78.4769444,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2249,united states of america,richmond,37.5536111,-77.4605556,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2250,united states of america,issaquah,47.5302778,-122.0313889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2251,united states of america,seattle,47.6063889,-122.3308333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2252,united states of america,milwaukee,43.0388889,-87.9063889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2253,argentina,buenos aires,-34.5875,-58.6725,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2254,argentina,buenos aires,-34.5875,-58.6725,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2255,brazil,belo horizonte,-19.916667,-43.933333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2256,brazil,porto alegre,-30.033333,-51.2,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2257,brazil,joinville,-26.3,-48.833333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2258,brazil,sao paulo,-23.473293,-46.665803,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2259,brazil,sao paulo,-23.473293,-46.665803,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2260,brazil,campina grande do sul,-25.3,-49.083333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2261,brazil,goiania,-16.666667,-49.266667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2262,brazil,passo fundo,-28.266667,-52.4,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2263,brazil,rio de janeiro,-22.9,-43.233333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2264,canada,edmonton,53.55,-113.5,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2265,canada,burnaby,49.25,-122.95,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2266,canada,ottawa,45.416667,-75.7,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2267,canada,chicoutimi,48.433333,-71.066667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2268,canada,montreal,45.5,-73.583333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2269,canada,montreal,45.5,-73.583333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2270,chile,santiago,-33.45,-70.666667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2271,chile,santiago,-33.45,-70.666667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2272,mexico,mexico,19.434167,-99.138611,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2273,mexico,tlalnepantla,19.526944,-99.221667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2274,mexico,monterrey,25.666667,-100.316667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2275,mexico,san luis potosi,22.15,-100.983333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2276,mexico,aguascalientes,21.883333,-102.3,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2277,mexico,chihuahua,28.633333,-106.083333,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2278,mexico,mexico,19.434167,-99.138611,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2279,mexico,monterrey,25.666667,-100.316667,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2280,united states of america,guaynabo,18.3594444,-66.1113889,NCT01633112,Multiple Sclerosis,RRMS,Drug,Phase 4,1960,Novartis Investigative Site
2281,france,nimes,43.833778,4.359623,NCT02664623,Multiple Sclerosis,All,Other,N/A,182,CHRU de Nîmes - Hôpital Universitaire Carémeau
2282,france,ales,44.131126,4.087188,NCT02664623,Multiple Sclerosis,All,Other,N/A,182,CH d'Alès
2283,united states of america,new york,40.7141667,-74.0063889,NCT01900093,Multiple Sclerosis,RRMS,Drug,Phase 2,10,Icahn School of Medicine at Mount Sinai
2284,united states of america,ann arbor,42.2708333,-83.7263889,NCT02544373,Multiple Sclerosis,All,Other,N/A,175,University of Michigan Medical Center
2285,united states of america,urbana,40.1105556,-88.2072222,NCT02318576,Multiple Sclerosis,All,Other,N/A,30,Motor control research lab
2286,canada,ottawa,45.416667,-75.7,NCT02239393,Multiple Sclerosis,All,Stem Cells,Phase 2,40,Ottawa Hospital - General Campus
2287,canada,winnipeg,49.883333,-97.166667,NCT02239393,Multiple Sclerosis,All,Stem Cells,Phase 2,40,Health Sciences Centre
2288,belgium,gent,51.05,3.716667,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2289,belgium,hasselt,50.933333,5.333333,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2290,germany,ravensburg,47.783333,9.616667,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2291,germany,trier,49.75,6.633333,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2292,italy,naples,40.833333,14.25,NCT02232061,Multiple Sclerosis,All,Drug,Phase 4,40,Novartis Investigative Site
2293,germany,munster,51.966667,7.633333,NCT02419378,Multiple Sclerosis,RRMS,Drug,Phase 4,15,Universitätsklinikum Münster - Klinik für Allgemeine Neurologie
2294,united states of america,seattle,47.6063889,-122.3308333,NCT01800604,Multiple Sclerosis,All,Behavioral,N/A,144,University of Washington - Ninth and Jefferson Building
2295,switzerland,aarau,47.389616,8.052354,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2296,switzerland,bern,46.916667,7.466667,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2297,switzerland,lugano,46.006182,8.951142,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2298,switzerland,luzern,47.083333,8.266667,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2299,switzerland,munsterlingen,47.630892,9.234947,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2300,switzerland,saint gallen,47.42539,9.377615,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2301,switzerland,wohlen,47.352359,8.278768,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2302,switzerland,zurich,47.366667,8.55,NCT02386566,Multiple Sclerosis,RRMS,Drug,N/A,88,Biogen Investigative Site
2303,united states of america,kirkland,47.6816667,-122.2075,NCT02736279,Multiple Sclerosis,All,Drug,Phase 4,25,EvergreenHealth MS Center
2304,canada,london,42.983333,-81.25,NCT02676739,Multiple Sclerosis,All,Drug,Phase 2-Phase 3,180,London Health Sciences Centre
2305,united kingdom,truro,50.261667,-5.043333,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2306,united kingdom,swansea,51.633333,-3.966667,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2307,united kingdom,romford,51.583333,0.2,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2308,united kingdom,basingstoke,51.266667,-1.083333,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2309,united kingdom,edinburgh,55.95,-3.2,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2310,united kingdom,glasgow,55.833333,-4.25,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2311,united kingdom,leicester,52.633333,-1.133333,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2312,united kingdom,liverpool,53.416667,-3,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2313,united kingdom,london,51.514125,-0.093689,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2314,united kingdom,london,51.514125,-0.093689,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2315,united kingdom,london,51.514125,-0.093689,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2316,united kingdom,london,51.514125,-0.093689,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2317,united kingdom,norwich,52.633333,1.3,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2318,united kingdom,nottingham,52.966667,-1.166667,NCT02335892,Multiple Sclerosis,RRMS,Behavioral,N/A,240,Novartis Investigative Site
2319,norway,drammen,59.7425,10.211667,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2320,norway,haukeland,60.363333,5.451389,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2321,norway,lillehammer,61.133333,10.5,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2322,norway,strommen,59.95,11,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2323,norway,molde,62.733333,7.183333,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2324,norway,oslo,59.916667,10.75,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2325,norway,stavanger,58.966667,5.75,NCT02471560,Multiple Sclerosis,RRMS,Drug,Phase 4,70,Biogen Investigative Site
2326,united states of america,baltimore,39.2902778,-76.6125,NCT02506751,Multiple Sclerosis,All,Drug,Phase 1,20,The Johns Hopkins Hospital
2327,france,caen,49.197188,-0.326822,NCT02518776,Multiple Sclerosis,All,Behavioral,N/A,80,Department of Neurologie - Caen Hospital University
2328,trinidad and tobago,san fernando,10.2833333,-61.4666667,NCT02587806,Multiple Sclerosis,RRMS,Stem Cells,Phase 1-Phase 2,69,Novo Cellular Medicine Institute
2329,united states of america,dallas,32.7833333,-96.8,NCT02739542,Multiple Sclerosis,All,Drug,Phase 4,210,UT Southwestern Medical Center
2330,belgium,overpelt,51.216667,5.416667,NCT02677077,Multiple Sclerosis,RRMS,Drug,Phase 4,300,Biogen Investigative Site
2331,united states of america,cullman,34.1747222,-86.8436111,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2332,united states of america,boca raton,26.3583333,-80.0833333,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2333,united states of america,new port richey,28.2438889,-82.7194444,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2334,united states of america,tampa,27.9472222,-82.4586111,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2335,united states of america,fulton,39.1508333,-76.9233333,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2336,united states of america,foxboro,42.0583333,-71.25,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2337,united states of america,deckerville,43.5266667,-82.7352778,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2338,united states of america,saint louis,38.6272222,-90.1977778,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2339,united states of america,stratford,39.8266667,-75.0158333,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2340,united states of america,teaneck,40.8975,-74.0163889,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2341,united states of america,new york,40.7141667,-74.0063889,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2342,united states of america,bala-cynwyd,40.0075,-75.2344444,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2343,united states of america,lititz,40.1572222,-76.3072222,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2344,united states of america,franklin,35.925,-86.8688889,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2345,united states of america,memphis,35.1494444,-90.0488889,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2346,united states of america,nashville,36.1658333,-86.7844444,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2347,united states of america,lubbock,33.5777778,-101.8547222,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2348,united states of america,round rock,30.5080556,-97.6786111,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2349,united states of america,fairfax,38.8461111,-77.3066667,NCT02652091,Multiple Sclerosis,RRMS,Drug,Phase 4,144,Bayer Investigative Site
2350,united states of america,portland,45.5236111,-122.675,NCT02263339,Multiple Sclerosis,All,Behavioral,N/A,14,Oregon Health & Science University
2351,united kingdom,leeds,53.8,-1.583333,NCT02641041,Multiple Sclerosis,All,Drug,Phase 1,24,Biogen Research Site
2352,germany,bamberg,49.866667,10.866667,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2353,germany,bochum,51.483333,7.216667,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2354,germany,bonn,50.733333,7.1,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2355,germany,dresden,51.05,13.75,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2356,germany,dusseldorf,51.216667,6.766667,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2357,germany,hanover,52.366667,9.716667,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2358,germany,heidelberg,49.416667,8.7,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2359,germany,rostock,54.083333,12.133333,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2360,germany,ulm,48.4,10,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2361,germany,wermsdorf,51.283333,12.95,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2362,switzerland,zurich,47.366667,8.55,NCT01705236,Multiple Sclerosis,RRMS,Other,Phase 4,100,Novartis Investigative Site
2363,germany,berlin,52.516667,13.4,NCT01647880,Multiple Sclerosis,CIS,Drug,Phase 2-Phase 3,88,Charité-Universitätsmedizin Berlin
2364,germany,potsdam,52.4,13.066667,NCT01647880,Multiple Sclerosis,CIS,Drug,Phase 2-Phase 3,88,Sankt Josefs Krankenhaus Potsdam Neurologie
2365,united states of america,dallas,32.7833333,-96.8,NCT01623076,NMOSD,NMOSD,Other,Phase 1,150,The University of Texas Southwestern Medical Center
2366,china,tianjin,39.142222,117.176667,NCT02249676,NMOSD,NMOSD,Stem Cells,Phase 2,15,Tianjin Medical University General Hospital
2367,united states of america,baltimore,39.2902778,-76.6125,NCT02276963,NMOSD,NMOSD,Drug,Phase 1,5,Johns Hopkins University School of Medicine
2368,japan,osaka,35.95,137.266667,NCT01845584,NMOSD,NMOSD,Drug,Phase 2,7,Nihon Investigative Site
2369,united states of america,birmingham,33.5205556,-86.8025,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2370,united states of america,sacramento,38.5816667,-121.4933333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2371,united states of america,san francisco,37.775,-122.4183333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2372,united states of america,aurora,39.7294444,-104.8313889,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2373,united states of america,maitland,28.6275,-81.3633333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2374,united states of america,chicago,41.85,-87.65,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2375,united states of america,kansas city,39.0997222,-94.5783333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2376,united states of america,baltimore,39.2902778,-76.6125,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2377,united states of america,detroit,42.3313889,-83.0458333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2378,united states of america,saint louis,38.6272222,-90.1977778,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2379,united states of america,raleigh,35.7719444,-78.6388889,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2380,united states of america,cleveland,41.4994444,-81.6955556,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2381,united states of america,dallas,32.7833333,-96.8,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2382,united states of america,houston,29.7630556,-95.3630556,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2383,australia,melbourne,-37.813938,144.963425,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2384,bulgaria,sofia,42.6833333,23.3166667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2385,bulgaria,varna,43.2166667,27.9166667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2386,canada,vancouver,49.25,-123.133333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2387,canada,montreal,45.5,-73.583333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2388,colombia,barranquilla,10.963889,-74.796389,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2389,colombia,bogota,4.649178,-74.062827,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2390,colombia,bogota,4.649178,-74.062827,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2391,colombia,cali,3.437222,-76.5225,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2392,czech republic,olomouc,49.59404,17.25119,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2393,czech republic,prague,50.083333,14.466667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2394,czech republic,teplice,50.646569,13.840138,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2395,estonia,tallinn,59.4338889,24.7280556,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2396,estonia,tartu,58.3661111,26.7361111,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2397,germany,berlin,52.516667,13.4,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2398,germany,dresden,51.05,13.75,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2399,germany,dusseldorf,51.216667,6.766667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2400,germany,leipzig,51.3,12.333333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2401,germany,marburg,50.816667,8.766667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2402,germany,munster,51.966667,7.633333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2403,germany,rostock,54.083333,12.133333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2404,germany,tubingen,48.533333,9.05,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2405,hong kong s.a.r.,hong kong,22.2833333,114.15,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2406,hong kong s.a.r.,hong kong,22.2833333,114.15,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2407,hong kong s.a.r.,sha tin,22.3833333,114.1833333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2408,japan,aomori-shi,40.824445,140.74,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2409,japan,kyoto-shi,35.021389,135.755556,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2410,japan,sendai,31.816667,130.3,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2411,japan,tokyo,35.685,139.751389,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2412,japan,tsukuba,36.083333,140.116667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2413,japan,ube,33.943056,131.251111,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2414,south korea,daegu,35.870278,128.591111,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2415,south korea,seoul,37.5985,126.9783,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2416,south korea,seoul,37.5985,126.9783,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2417,south korea,seoul,37.5985,126.9783,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2418,mexico,mexico,19.434167,-99.138611,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2419,mexico,mexico,19.434167,-99.138611,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2420,mexico,monterrey,25.666667,-100.316667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2421,mexico,san luis potosi,22.15,-100.983333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2422,moldova,chisinau,47.005556,28.8575,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2423,new zealand,auckland,-36.866667,174.766667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2424,new zealand,christchurch,-43.533333,172.633333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2425,peru,bellavista,-12.0666667,-77.1333333,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2426,peru,lima,-12.05,-77.05,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2427,poland,katowice,50.258415,19.027545,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2428,poland,krakow,50.083333,19.916667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2429,poland,lublin,51.25,22.566667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2430,poland,lodz,51.75,19.466667,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2431,poland,olsztyn,53.779949,20.494162,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2432,poland,warsaw,52.25,21,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2433,russia,belgorod,50.610743,36.580152,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2434,russia,kazan,55.78874,49.122144,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2435,russia,khabarovsk,48.480833,135.092778,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2436,russia,moscow,55.752222,37.615556,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2437,russia,nizhniy novgorod,56.326944,44.0075,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2438,russia,novosibirsk,55.0415,82.9346,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2439,russia,omsk,55,73.4,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2440,russia,saint petersburg,59.894444,30.264167,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2441,russia,ufa,54.785167,56.045621,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2442,south africa,cape town,-33.925839,18.423218,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2443,spain,madrid,40.408566,-3.69222,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2444,taiwan,changhua,24.08,120.5425,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2445,taiwan,hualien,23.9833333,121.6,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2446,taiwan,tainan,22.9933333,120.2036111,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2447,thailand,bangkok,13.753979,100.501444,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2448,thailand,amphoe ban muang,17.850796,103.569389,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2449,turkey,istanbul,41.018611,28.964722,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2450,turkey,izmir,38.412726,27.138376,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2451,turkey,samsun,41.286667,36.33,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2452,ukraine,dnipropetrovsk,48.46298,35.039043,NCT02200770,NMOSD,NMOSD,Biological,Phase 2-Phase 3,212,AstraZeneca Investigative Site
2453,united states of america,scottsdale,33.5091667,-111.8983333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Mayo Clinic Arizona
2454,united states of america,oceanside,33.1958333,-117.3786111,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,The Research Center of Southern California
2455,united states of america,newark,39.6836111,-75.75,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Christiana Care Neurology Spec -
2456,united states of america,orlando,28.5380556,-81.3794444,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Neurological Services of Orlando
2457,united states of america,fort wayne,41.1305556,-85.1288889,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Allied Physicians Inc. of Fort Wayne
2458,united states of america,kansas city,39.0997222,-94.5783333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Kansas Medical Center
2459,united states of america,louisville,38.2541667,-85.7594444,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Community Medical Associates - Inc. -
2460,united states of america,baltimore,39.2902778,-76.6125,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Maryland Medical Center
2461,united states of america,baltimore,39.2902778,-76.6125,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,John Hopkins University School of Medicine
2462,united states of america,rochester,44.0216667,-92.4697222,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Mayo Clinic - Rochester
2463,united states of america,saint louis,38.6272222,-90.1977778,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Washington University School of Medicine
2464,united states of america,new york,40.7141667,-74.0063889,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Multiple Sclerosis Comprehensive Care Center NYU Langone Medical Center
2465,united states of america,new york,40.7141667,-74.0063889,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Mount Sinai School of Medicine
2466,united states of america,rochester,44.0216667,-92.4697222,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Rochester Medical Center
2467,united states of america,durham,35.9938889,-78.8988889,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Duke University Health System
2468,united states of america,columbus,39.9611111,-82.9988889,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Ohio Health Reserach Institute
2469,united states of america,columbus,39.9611111,-82.9988889,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Ohio State University Medical Center
2470,united states of america,philadelphia,39.9522222,-75.1641667,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Pennsylvania School of Medicine
2471,united states of america,pittsburgh,40.4405556,-79.9961111,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Pittsburgh
2472,united states of america,salt lake city,40.7608333,-111.8902778,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Utah
2473,united states of america,seattle,47.6063889,-122.3308333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Swedish Medical Center
2474,argentina,pilar,-34.457607,-58.913845,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Austral
2475,argentina,rosario,-32.946818,-60.639317,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Fundacion Rosarina de Neuro Rehabilitacion
2476,argentina,rosario,-32.946818,-60.639317,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Departamento de Investigaciones Clinicas Sanatorio Norte
2477,argentina,buenos aires,-34.5875,-58.6725,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,ALPI-Inst. de Rehabilitacion Marcelo Fitte
2478,australia,camperdown,-33.9,151.183333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Brain and Mind Research Institute
2479,australia,liverpool,-33.9,150.933333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Liverpool Hospital
2480,australia,gold coast,-28.00029,153.430878,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Griffith University
2481,australia,fitzroy,-37.783333,144.983333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,St. Vincent's Hospital
2482,austria,graz,47.066667,15.45,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,LKH Graz
2483,austria,innsbruck,47.266667,11.4,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Klinik Innsbruck
2484,canada,ottawa,45.416667,-75.7,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,The Ottawa Hospital
2485,canada,montreal,45.5,-73.583333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Montreal Neurological Institute and Hospital
2486,colombia,floridablanca,7.062222,-73.08644,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Fundacion Cardiovascular de Colombia
2487,czech republic,teplice,50.646569,13.840138,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Krajska zdravotni - a.s. - Nemocnice
2488,denmark,aarhus,56.153423,10.22553,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Århus Universitetshospital
2489,france,strasbourg,48.600381,7.787355,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,CHU Hautepierre
2490,france,nimes,43.833778,4.359623,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,CHU de Nimes
2491,france,montpellier,43.61092,3.87723,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hôpital Gui de Chauliac
2492,france,bron,45.740218,4.922415,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hopital Neurologique Pierre Wertheimer
2493,germany,heidelberg,49.416667,8.7,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University Hospital Heidelberg
2494,germany,munich,48.15,11.5833,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Neurologische Klinik und Poliklinik
2495,germany,regensburg,49.015,12.095556,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University Hospital Regensburg
2496,germany,bochum,51.483333,7.216667,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Bochum - Nordrhein Westfalen - Germany - 44791
2497,germany,dusseldorf,51.216667,6.766667,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Dusseldorf - Nordrhein Westfalen - Germany - 40225
2498,germany,berlin,52.516667,13.4,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Berlin - Germany - 10117
2499,germany,hanover,52.366667,9.716667,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hannover - Germany - 30625
2500,germany,rostock,54.083333,12.133333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Rostock - Germany - 18147
2501,hong kong s.a.r.,hong kong,22.2833333,114.15,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,University of Hong Kong - Queen Mary Hospital
2502,hong kong s.a.r.,sha tin,22.3833333,114.1833333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Prince of Wales Hospital
2503,italy,palermo,38.116667,13.366667,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Fondazione Istituto San Raffaele - G.Giglio di Cefalù
2504,italy,catania,37.5,15.1,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Policlinico di Catania
2505,italy,naples,40.833333,14.25,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Azienda Ospedaliera Universitaria
2506,italy,padova,45.416667,11.883333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Azienda Ospedaliera di Padova
2507,italy,pavia,45.166667,9.166667,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Fondazione Instituto Neurologico Casimiro Mondino
2508,italy,rome,41.9,12.483333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Azienda Ospedaliera San Camillo Forlanini
2509,italy,rome,41.9,12.483333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Azienda Ospedaliera Sant'Andrea-Università di Roma La Sapienza
2510,japan,chiba-shi,35.604722,140.123334,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Chiba University Hospital
2511,japan,kyoto-shi,35.021389,135.755556,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Kyoto Min-iren Chuo Hospital
2512,japan,sendai,31.816667,130.3,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Tohoku University Hospital
2513,japan,ginowan,26.26265,127.761472,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,NHO Okinawa National Hospital
2514,japan,tokyo,35.685,139.751389,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Tokyo Medical and Dental University
2515,japan,tokyo,35.685,139.751389,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Musashino Red Cross Hospital
2516,japan,ube,33.943056,131.251111,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Yamaguchi University Hospital
2517,japan,fukuoka-shi,33.606389,130.418056,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Kyushu University Hospital
2518,japan,nagasaki,34.338333,133.14,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,NHO Nagasaki Kawatana Medical Center
2519,japan,niigata,37.902222,139.023611,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Niigata University Medical & Dental Hospital
2520,south korea,seoul,37.5985,126.9783,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,National Cancer Center
2521,south korea,seoul,37.5985,126.9783,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Korea University Anam Hospital
2522,south korea,seoul,37.5985,126.9783,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Samsung Medical Center
2523,south korea,seoul,37.5985,126.9783,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Seoul University National Hospital
2524,south korea,seoul,37.5985,126.9783,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Severance Hospital - Yonsei University
2525,south korea,seoul,37.5985,126.9783,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Asan Medical Center
2526,russia,kazan,55.78874,49.122144,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Republican Clinical Hospital for Rehabilitation of Healthcare Ministry of Republic of Tatarstan
2527,russia,krasnoyarsk,56.0091,92.8628,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,"SBEI ""Krasnoyarsk SMU n.a. Prof. V.F. Voyno-Yasenetsky"""
2528,russia,moscow,55.752222,37.615556,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,"State Healthcare Institution of city of Moscow ""City Clinical Hospital #11"""
2529,russia,novosibirsk,55.0415,82.9346,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Federal State Budget Institution of Healthcare - Siberian District Medical Center of FMBA of Russia
2530,russia,rostov-on-don,47.23135,39.723284,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,"SEIHPE ""Rostov SMU of MoH of RF"""
2531,russia,saint petersburg,59.894444,30.264167,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,First Pavlov State Medical University of St.Petersburg
2532,russia,saint petersburg,59.894444,30.264167,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,"Saint-Petersburg SHI ""City Clinical Hospital #31"""
2533,singapore,singapore,1.2930556,103.8558333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,National University Hospital
2534,singapore,singapore,1.2930556,103.8558333,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,National Neuroscience Institute
2535,spain,zaragoza,41.64531,-0.884861,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Miguel Servet
2536,spain,bilboa,43.260919,-2.938764,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital de Cruces
2537,spain,cordoba,37.89155,-4.772748,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Reina Sofia
2538,spain,madrid,40.408566,-3.69222,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario de la Princesa
2539,spain,madrid,40.408566,-3.69222,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Clinico San Carlos
2540,spain,sevilla,37.382408,-5.976133,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hospital Universitario Virgen Macarena
2541,taiwan,taipei,25.0391667,121.525,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Cheng Hsin General Hospital
2542,taiwan,taipei,25.0391667,121.525,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,National Taiwan University Hospital
2543,turkey,ankara,39.911652,32.840305,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Hacettepe University Medical Faculty
2544,turkey,edirne,41.675745,26.558665,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Trakya University Medical Faculty
2545,turkey,istanbul,41.018611,28.964722,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Istanbul Bilim Universty Medical Fac.
2546,turkey,istanbul,41.018611,28.964722,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Istanbul University Cerrahpasa Medical Faculty
2547,turkey,istanbul,41.018611,28.964722,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Istanbul University Istanbul Medical Faculty
2548,turkey,izmir,38.412726,27.138376,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Dokuz Eylul University Medicine Faculty
2549,turkey,kocaeli,40.766944,29.916944,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Kocaeli University Medical Faculty
2550,turkey,samsun,41.286667,36.33,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Ondokuz Mayis Univ. Med. Fac.
2551,turkey,trabzon,41.005,39.726944,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Karadeniz Tecnical Uni. Med. Fac.
2552,united kingdom,liverpool,53.416667,-3,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,The Walton Centre
2553,united kingdom,london,51.514125,-0.093689,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,Royal Free Hospital
2554,united kingdom,oxford,51.75,-1.25,NCT01892345,NMOSD,NMOSD,Drug,Phase 3,132,John Radcliffe Hospital
2555,united states of america,chicago,41.85,-87.65,NCT00787722,NMOSD,NMOSD,Stem Cells,Phase 1,10,Northwestern University - Feinberg School of Medicine
2556,spain,barcelona,41.398371,2.1741,NCT02283671,Multiple Sclerosis,All,Drug,Phase 1,12,Hospital Clinic of Barcelona
2557,japan,osaka,35.95,137.266667,NCT02028884,NMOSD,NMOSD,Drug,Phase 3,70,Chugai Investigative Site
2558,united states of america,orange,33.7877778,-117.8522222,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,UC Irvine Institute for Clinical and Translational Science
2559,united states of america,sacramento,38.5816667,-121.4933333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,UC Davis Medical Center
2560,united states of america,aurora,39.7294444,-104.8313889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Colorado Denver
2561,united states of america,washington,38.895,-77.0366667,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,The George Washington University Medical Faculty Associates
2562,united states of america,miami,25.7738889,-80.1938889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Neurology Associate Group
2563,united states of america,miami,25.7738889,-80.1938889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,JDH Medical Group
2564,united states of america,miami,25.7738889,-80.1938889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Miami
2565,united states of america,sarasota,27.3361111,-82.5308333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Negroski - Sutherland & Hanes Neurology - LLP
2566,united states of america,vero beach,27.6383333,-80.3975,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Vero Neurology
2567,united states of america,columbus,39.9611111,-82.9988889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Columbus Research & Wellness Clinic
2568,united states of america,chicago,41.85,-87.65,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Northwestern University
2569,united states of america,chicago,41.85,-87.65,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Chicago Medical Center
2570,united states of america,northbrook,42.1275,-87.8288889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Consultants in Neurology - Ltd.
2571,united states of america,peoria,40.6936111,-89.5888889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Illinois College of Medicine / Illinois Neurologic Institute
2572,united states of america,kansas city,39.0997222,-94.5783333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Kansas Medical Center
2573,united states of america,lenexa,38.9536111,-94.7333333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Rowe Neurology Institute
2574,united states of america,baltimore,39.2902778,-76.6125,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,The Johns Hopkins Hospital
2575,united states of america,ann arbor,42.2708333,-83.7263889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Michigan
2576,united states of america,detroit,42.3313889,-83.0458333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Wayne State University
2577,united states of america,new york,40.7141667,-74.0063889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,New York Eye and Ear Infirmary of Mount Sinai
2578,united states of america,new york,40.7141667,-74.0063889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Weill Cornell Medical College
2579,united states of america,patchogue,40.7655556,-73.0155556,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,South Shore Neurologic Associates
2580,united states of america,rochester,44.0216667,-92.4697222,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Rochester Multiple Sclerosis Ct / Strong Neurology
2581,united states of america,chapel hill,35.9130556,-79.0561111,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of North Carolina at Chapel Hill
2582,united states of america,charlotte,35.2269444,-80.8433333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,The Neurological Institute
2583,united states of america,cincinnati,39.1619444,-84.4569444,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Cincinnati
2584,united states of america,columbus,39.9611111,-82.9988889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Ohio Health Neurological Physicians
2585,united states of america,oklahoma city,35.4675,-97.5161111,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,OMRF Multiple Sclerosis Center of Excellence
2586,united states of america,tualatin,45.3841667,-122.7627778,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Legacy Health Systems / Oregon Neurology - PC
2587,united states of america,philadelphia,39.9522222,-75.1641667,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Thomas Jefferson University - The Comprehensive MS Center
2588,united states of america,dallas,32.7833333,-96.8,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of Texas Southwestern Medical School
2589,united states of america,round rock,30.5080556,-97.6786111,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Central Texas Neurology Consultants
2590,united states of america,san antonio,29.4238889,-98.4933333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,UT Medicine San Antonio
2591,united states of america,richmond,37.5536111,-77.4605556,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Virginia Commonwealth University - Medical Center
2592,united states of america,milwaukee,43.0388889,-87.9063889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Wheaton Franciscan Healthcare
2593,canada,vancouver,49.25,-123.133333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,University of British Columbia
2594,canada,kingston,44.233333,-76.483333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Kingston General Hospital
2595,canada,greenfield park,45.5,-73.483333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Recherche Sepmus - Inc
2596,canada,montreal,45.5,-73.583333,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,CHUM-Hôpital Notre-Dame
2597,united states of america,guaynabo,18.3594444,-66.1113889,NCT02073279,NMOSD,NMOSD,Drug,Phase 3,70,Caribbean Neurological Center Centro Internacional de Mercadeo
2598,germany,freiburg,48,7.85,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Medical Center - University of Freiburg - Eye Hospital
2599,germany,heidelberg,49.416667,8.7,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Heidelberg University Hospital - Department of Neurooncology
2600,germany,tubingen,48.533333,9.05,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Tuebingen University Hospital
2601,germany,erlangen,49.589722,11.003889,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Hospital Erlangen
2602,germany,munich,48.15,11.5833,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Hospital of Munich
2603,germany,munich,48.15,11.5833,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Hospital Klinikum rechts der Isar - Munich
2604,germany,gottingen,51.533333,9.933333,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Medical Center Goettingen
2605,germany,hanover,52.366667,9.716667,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Hannover Medical School
2606,germany,dusseldorf,51.216667,6.766667,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Duesseldorf University Hospital
2607,germany,essen,51.45,7.016667,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Essen University Hospital
2608,germany,mainz,50,8.271111,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Medical Center of the Johannes Gutenberg University Mainz
2609,germany,berlin,52.516667,13.4,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,Charité Berlin
2610,germany,hamburg,53.55,10,NCT01962571,NMOSD,NMOSD,Drug,Phase 3,100,University Medical Center Hamburg-Eppendorf
2611,united states of america,portland,45.5236111,-122.675,NCT01294176,NMOSD,NMOSD,Drug,Phase 1,54,Oregon Health & Science University
2612,austria,vienna,48.2,16.366667,NCT01879527,NMOSD,NMOSD,Drug,Phase 2,78,Medical University of Vienna - Department of Neurology
